EP3153585B1 - Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants - Google Patents
Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants Download PDFInfo
- Publication number
- EP3153585B1 EP3153585B1 EP16194415.2A EP16194415A EP3153585B1 EP 3153585 B1 EP3153585 B1 EP 3153585B1 EP 16194415 A EP16194415 A EP 16194415A EP 3153585 B1 EP3153585 B1 EP 3153585B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nucleic acid
- neena
- acid molecule
- plant
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims description 238
- 102000039446 nucleic acids Human genes 0.000 title claims description 208
- 108020004707 nucleic acids Proteins 0.000 title claims description 208
- 230000014509 gene expression Effects 0.000 title claims description 185
- 230000002708 enhancing effect Effects 0.000 title claims description 28
- 230000001105 regulatory effect Effects 0.000 title description 17
- 241000196324 Embryophyta Species 0.000 claims description 227
- 239000013598 vector Substances 0.000 claims description 76
- 238000000034 method Methods 0.000 claims description 62
- 230000009261 transgenic effect Effects 0.000 claims description 60
- 230000000295 complement effect Effects 0.000 claims description 30
- 239000013604 expression vector Substances 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 18
- 239000012634 fragment Substances 0.000 claims description 14
- 238000003259 recombinant expression Methods 0.000 claims description 14
- 238000011144 upstream manufacturing Methods 0.000 claims description 14
- 108700009124 Transcription Initiation Site Proteins 0.000 claims description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 10
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 108020003589 5' Untranslated Regions Proteins 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 230000002441 reversible effect Effects 0.000 claims description 7
- 238000004113 cell culture Methods 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 4
- 230000006819 RNA synthesis Effects 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 239000012847 fine chemical Substances 0.000 claims description 2
- 102000053602 DNA Human genes 0.000 description 129
- 108020004414 DNA Proteins 0.000 description 128
- 108090000623 proteins and genes Proteins 0.000 description 95
- 210000001519 tissue Anatomy 0.000 description 67
- 210000004027 cell Anatomy 0.000 description 65
- 125000003729 nucleotide group Chemical group 0.000 description 55
- 108091028043 Nucleic acid sequence Proteins 0.000 description 52
- 239000002773 nucleotide Substances 0.000 description 52
- 230000009466 transformation Effects 0.000 description 39
- 108700008625 Reporter Genes Proteins 0.000 description 38
- 102000004169 proteins and genes Human genes 0.000 description 35
- 235000018102 proteins Nutrition 0.000 description 34
- 230000000694 effects Effects 0.000 description 32
- 108091026890 Coding region Proteins 0.000 description 31
- 229920002477 rna polymer Polymers 0.000 description 31
- 108091092195 Intron Proteins 0.000 description 28
- 108020004999 messenger RNA Proteins 0.000 description 26
- 240000007594 Oryza sativa Species 0.000 description 24
- 210000001938 protoplast Anatomy 0.000 description 24
- 240000008042 Zea mays Species 0.000 description 23
- 241000219195 Arabidopsis thaliana Species 0.000 description 21
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 20
- 239000002585 base Substances 0.000 description 20
- 239000002609 medium Substances 0.000 description 20
- 108060001084 Luciferase Proteins 0.000 description 19
- 239000005089 Luciferase Substances 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 18
- 108090000331 Firefly luciferases Proteins 0.000 description 17
- 229920003266 Leaf® Polymers 0.000 description 17
- 235000007164 Oryza sativa Nutrition 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 17
- 230000001404 mediated effect Effects 0.000 description 17
- 235000009566 rice Nutrition 0.000 description 17
- 241000894007 species Species 0.000 description 17
- 240000002791 Brassica napus Species 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 238000013518 transcription Methods 0.000 description 15
- 230000035897 transcription Effects 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 235000010469 Glycine max Nutrition 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 13
- 230000001052 transient effect Effects 0.000 description 12
- 241000589158 Agrobacterium Species 0.000 description 11
- 244000068988 Glycine max Species 0.000 description 11
- 241000209140 Triticum Species 0.000 description 11
- 235000021307 Triticum Nutrition 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 10
- 235000009973 maize Nutrition 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 230000006798 recombination Effects 0.000 description 10
- 238000005215 recombination Methods 0.000 description 10
- 238000010186 staining Methods 0.000 description 10
- 235000006008 Brassica napus var napus Nutrition 0.000 description 9
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 9
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 229930195725 Mannitol Natural products 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 244000038559 crop plants Species 0.000 description 9
- 230000002068 genetic effect Effects 0.000 description 9
- 239000000594 mannitol Substances 0.000 description 9
- 235000010355 mannitol Nutrition 0.000 description 9
- 108010052090 Renilla Luciferases Proteins 0.000 description 8
- 235000002595 Solanum tuberosum Nutrition 0.000 description 8
- 244000061456 Solanum tuberosum Species 0.000 description 8
- 108700019146 Transgenes Proteins 0.000 description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 8
- 230000003321 amplification Effects 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 235000005822 corn Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 8
- 230000010354 integration Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 230000002103 transcriptional effect Effects 0.000 description 8
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 7
- 240000000385 Brassica napus var. napus Species 0.000 description 7
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 7
- 244000299507 Gossypium hirsutum Species 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 102000040430 polynucleotide Human genes 0.000 description 7
- 108091033319 polynucleotide Proteins 0.000 description 7
- 239000002157 polynucleotide Substances 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 6
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 244000062793 Sorghum vulgare Species 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 102000053187 Glucuronidase Human genes 0.000 description 5
- 108010060309 Glucuronidase Proteins 0.000 description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 description 5
- 240000005979 Hordeum vulgare Species 0.000 description 5
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 108020005067 RNA Splice Sites Proteins 0.000 description 5
- 240000000111 Saccharum officinarum Species 0.000 description 5
- 235000007201 Saccharum officinarum Nutrition 0.000 description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 230000000692 anti-sense effect Effects 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 108010058731 nopaline synthase Proteins 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 108020005544 Antisense RNA Proteins 0.000 description 4
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 4
- 241000218631 Coniferophyta Species 0.000 description 4
- 230000007023 DNA restriction-modification system Effects 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108700024394 Exon Proteins 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 241000218922 Magnoliophyta Species 0.000 description 4
- 240000003433 Miscanthus floridulus Species 0.000 description 4
- 241000234295 Musa Species 0.000 description 4
- 108020004511 Recombinant DNA Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 235000021536 Sugar beet Nutrition 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 239000013611 chromosomal DNA Substances 0.000 description 4
- 239000003184 complementary RNA Substances 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- -1 rRNA Proteins 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- FLUSEOZMBNGLSB-HNTFPEDGSA-N (2S,3R,4R,5R,6R)-2-bromo-3-chloro-3,4,5,6-tetrahydroxy-4-(1H-indol-2-yl)oxane-2-carboxylic acid Chemical compound O[C@H]1[C@H](O)O[C@](Br)(C(O)=O)[C@](O)(Cl)[C@@]1(O)C1=CC2=CC=CC=C2N1 FLUSEOZMBNGLSB-HNTFPEDGSA-N 0.000 description 3
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 241000195940 Bryophyta Species 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241001057636 Dracaena deremensis Species 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000004431 Linum usitatissimum Nutrition 0.000 description 3
- 240000006240 Linum usitatissimum Species 0.000 description 3
- 108091027974 Mature messenger RNA Proteins 0.000 description 3
- 240000004658 Medicago sativa Species 0.000 description 3
- 240000009164 Petroselinum crispum Species 0.000 description 3
- 240000004713 Pisum sativum Species 0.000 description 3
- 235000010582 Pisum sativum Nutrition 0.000 description 3
- 108010068086 Polyubiquitin Proteins 0.000 description 3
- 102100037935 Polyubiquitin-C Human genes 0.000 description 3
- 108020004688 Small Nuclear RNA Proteins 0.000 description 3
- 102000039471 Small Nuclear RNA Human genes 0.000 description 3
- 102000042773 Small Nucleolar RNA Human genes 0.000 description 3
- 108020003224 Small Nucleolar RNA Proteins 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000000408 embryogenic effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- WYXYBEOWQBGFQB-UHFFFAOYSA-N n-benzyl-7h-purin-2-amine Chemical compound N=1C=C2NC=NC2=NC=1NCC1=CC=CC=C1 WYXYBEOWQBGFQB-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 125000002652 ribonucleotide group Chemical group 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 2
- 108020005345 3' Untranslated Regions Proteins 0.000 description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 2
- 108010002610 5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase Proteins 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 108010016281 ADP-Ribosylation Factor 1 Proteins 0.000 description 2
- 102100034341 ADP-ribosylation factor 1 Human genes 0.000 description 2
- 101710103719 Acetolactate synthase large subunit Proteins 0.000 description 2
- 101710182467 Acetolactate synthase large subunit IlvB1 Proteins 0.000 description 2
- 101710171176 Acetolactate synthase large subunit IlvG Proteins 0.000 description 2
- 101710176702 Acetolactate synthase small subunit Proteins 0.000 description 2
- 101710147947 Acetolactate synthase small subunit 1, chloroplastic Proteins 0.000 description 2
- 101710095712 Acetolactate synthase, mitochondrial Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 2
- 241000219194 Arabidopsis Species 0.000 description 2
- 101100133905 Arabidopsis thaliana NIT1 gene Proteins 0.000 description 2
- 101100115693 Arabidopsis thaliana OASA1 gene Proteins 0.000 description 2
- 101100530463 Arabidopsis thaliana RPS17D gene Proteins 0.000 description 2
- 101100201106 Arabidopsis thaliana RPS5A gene Proteins 0.000 description 2
- 101100101568 Arabidopsis thaliana UBQ11 gene Proteins 0.000 description 2
- 101100101570 Arabidopsis thaliana UBQ14 gene Proteins 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 241000724256 Brome mosaic virus Species 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 101710109085 Cysteine synthase, chloroplastic/chromoplastic Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102100031334 Elongation factor 2 Human genes 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 102100027297 Fatty acid 2-hydroxylase Human genes 0.000 description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 101000937693 Homo sapiens Fatty acid 2-hydroxylase Proteins 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 229930182821 L-proline Natural products 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 241000227653 Lycopersicon Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000196323 Marchantiophyta Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 101710138316 O-acetylserine sulfhydrylase Proteins 0.000 description 2
- 108010077519 Peptide Elongation Factor 2 Proteins 0.000 description 2
- 235000002770 Petroselinum crispum Nutrition 0.000 description 2
- 244000062780 Petroselinum sativum Species 0.000 description 2
- 101710139641 Polyadenylate-binding protein 2 Proteins 0.000 description 2
- 102100039427 Polyadenylate-binding protein 2 Human genes 0.000 description 2
- 101710196435 Probable acetolactate synthase large subunit Proteins 0.000 description 2
- 101710181764 Probable acetolactate synthase small subunit Proteins 0.000 description 2
- 101710104000 Putative acetolactate synthase small subunit Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 108091027967 Small hairpin RNA Proteins 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000012308 Tagetes Nutrition 0.000 description 2
- 241000736851 Tagetes Species 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 108090000848 Ubiquitin Proteins 0.000 description 2
- 102000044159 Ubiquitin Human genes 0.000 description 2
- 102000003431 Ubiquitin-Conjugating Enzyme Human genes 0.000 description 2
- 108060008747 Ubiquitin-Conjugating Enzyme Proteins 0.000 description 2
- 241000482268 Zea mays subsp. mays Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 108010079058 casein hydrolysate Proteins 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 229940088530 claforan Drugs 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000012411 cloning technique Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- 238000010864 dual luciferase reporter gene assay Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 235000011197 perejil Nutrition 0.000 description 2
- 150000004713 phosphodiesters Chemical class 0.000 description 2
- 244000000003 plant pathogen Species 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 210000001324 spliceosome Anatomy 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- POFFJVRXOKDESI-UHFFFAOYSA-N 1,3,5,7-tetraoxa-4-silaspiro[3.3]heptane-2,6-dione Chemical compound O1C(=O)O[Si]21OC(=O)O2 POFFJVRXOKDESI-UHFFFAOYSA-N 0.000 description 1
- PDOGCHRAEBICEX-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl.OC(=O)COC1=CC=C(Cl)C=C1Cl PDOGCHRAEBICEX-UHFFFAOYSA-N 0.000 description 1
- 108020005065 3' Flanking Region Proteins 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 102100039882 40S ribosomal protein S17 Human genes 0.000 description 1
- 101710131775 40S ribosomal protein S17 Proteins 0.000 description 1
- 102100023779 40S ribosomal protein S5 Human genes 0.000 description 1
- 101710107635 40S ribosomal protein S5 Proteins 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 108010075604 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Proteins 0.000 description 1
- 102000011848 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Human genes 0.000 description 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical class BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- 102100033416 60S acidic ribosomal protein P1 Human genes 0.000 description 1
- 101710123000 60S acidic ribosomal protein P1 Proteins 0.000 description 1
- 102100040540 60S ribosomal protein L3 Human genes 0.000 description 1
- 101710117444 60S ribosomal protein L3 Proteins 0.000 description 1
- 101000889837 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) Protein CysO Proteins 0.000 description 1
- 235000016626 Agrimonia eupatoria Nutrition 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000208306 Apium Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 101100500643 Arabidopsis thaliana A4 gene Proteins 0.000 description 1
- 101100379478 Arabidopsis thaliana ARF1 gene Proteins 0.000 description 1
- 101100012532 Arabidopsis thaliana FAH1 gene Proteins 0.000 description 1
- 101100001398 Arabidopsis thaliana FBA8 gene Proteins 0.000 description 1
- 101100280852 Arabidopsis thaliana FDC1 gene Proteins 0.000 description 1
- 101100503658 Arabidopsis thaliana GAPC2 gene Proteins 0.000 description 1
- 101100281397 Arabidopsis thaliana LFNR1 gene Proteins 0.000 description 1
- 101100237205 Arabidopsis thaliana MS2 gene Proteins 0.000 description 1
- 101100353514 Arabidopsis thaliana PAB2 gene Proteins 0.000 description 1
- 101100302455 Arabidopsis thaliana RPL3A gene Proteins 0.000 description 1
- 101100528091 Arabidopsis thaliana RPP1A gene Proteins 0.000 description 1
- 101100153782 Arabidopsis thaliana TPT gene Proteins 0.000 description 1
- 101100371493 Arabidopsis thaliana UBC1 gene Proteins 0.000 description 1
- 101100048082 Arabidopsis thaliana UBC28 gene Proteins 0.000 description 1
- 101100539163 Arabidopsis thaliana UBC9 gene Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241001467606 Bacillariophyceae Species 0.000 description 1
- 241000206761 Bacillariophyta Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000743774 Brachypodium Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 101100380241 Caenorhabditis elegans arx-2 gene Proteins 0.000 description 1
- 101000909256 Caldicellulosiruptor bescii (strain ATCC BAA-1888 / DSM 6725 / Z-1320) DNA polymerase I Proteins 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108091092236 Chimeric RNA Proteins 0.000 description 1
- 241000196319 Chlorophyceae Species 0.000 description 1
- 108091033380 Coding strand Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 241000592295 Cycadophyta Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000208175 Daucus Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 102100027887 Deaminated glutathione amidase Human genes 0.000 description 1
- 238000003718 Dual-Luciferase Reporter Assay System Methods 0.000 description 1
- 101710103942 Elongation factor 1-alpha Proteins 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101100048413 Escherichia coli (strain K12) ulaC gene Proteins 0.000 description 1
- 241000195623 Euglenida Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108010074122 Ferredoxins Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 238000012357 Gap analysis Methods 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 239000005980 Gibberellic acid Substances 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101001012787 Homo sapiens Eukaryotic translation initiation factor 1 Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 235000002262 Lycopersicon Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000195947 Lycopodium Species 0.000 description 1
- 235000010624 Medicago sativa Nutrition 0.000 description 1
- 241000427649 Melongena Species 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 108010033272 Nitrilase Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108700027408 O-acetylhomoserine (thiol)-lyase Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 1
- 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000985694 Polypodiopsida Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 101000902592 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) DNA polymerase Proteins 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 101150108890 RPP1A gene Proteins 0.000 description 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 description 1
- 244000081426 Ranunculus ficaria Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 101100304648 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rpl301 gene Proteins 0.000 description 1
- 101100201109 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rps5 gene Proteins 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 102100037262 Ubiquitin-conjugating enzyme E2 B Human genes 0.000 description 1
- 101710173927 Ubiquitin-conjugating enzyme E2-17 kDa Proteins 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000206764 Xanthophyceae Species 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 101150092805 actc1 gene Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 101150112048 apxIIIA gene Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 239000012152 bradford reagent Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229960002727 cefotaxime sodium Drugs 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 229940038649 clavulanate potassium Drugs 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 238000003468 luciferase reporter gene assay Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 108091064355 mitochondrial RNA Proteins 0.000 description 1
- 239000006934 mmb medium Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 239000004069 plant analysis Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- ABVRVIZBZKUTMK-JSYANWSFSA-M potassium clavulanate Chemical compound [K+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 ABVRVIZBZKUTMK-JSYANWSFSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 101150103042 ptxA gene Proteins 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000014891 regulation of alternative nuclear mRNA splicing, via spliceosome Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000021749 root development Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- RWVGQQGBQSJDQV-UHFFFAOYSA-M sodium;3-[[4-[(e)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-n-ethyl-3-methylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=C1 RWVGQQGBQSJDQV-UHFFFAOYSA-M 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960004075 ticarcillin disodium Drugs 0.000 description 1
- ZBBCUBMBMZNEME-QBGWIPKPSA-L ticarcillin disodium Chemical compound [Na+].[Na+].C=1([C@@H](C([O-])=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)C=CSC=1 ZBBCUBMBMZNEME-QBGWIPKPSA-L 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 108040005733 triose-phosphate:phosphate antiporter activity proteins Proteins 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 235000020138 yakult Nutrition 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/823—Reproductive tissue-specific promoters
- C12N15/8234—Seed-specific, e.g. embryo, endosperm
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the present invention is in the field of plant molecular biology and provides methods for production of high expressing constitutive promoters and the production of plants with enhanced constitutive expression of nucleic acids wherein nucleic acid expression enhancing nucleic acids (NEENAs) are functionally linked to said promoters and/or introduced into plants.
- NEENAs nucleic acid expression enhancing nucleic acids
- transgenes in plants are strongly affected by various external and internal factors resulting in a variable and unpredictable level of transgene expression. Often a high number of transformants have to be produced and analyzed in order to identify lines with desirable expression strength. As transformation and screening of lines with desirable expression strength is costly and labor intensive there is a need for high expression of one ore more transgenes in a plant. This problem is especially pronounced, when several genes have to be coordinately expressed in a transgenic plant in order to achieve a specific effect as a plant has to be identified in which each and every gene is strongly expressed.
- expression of a transgene can vary significantly, depending on construct design and positional effects of the T-DNA insertion locus in individual transformation events. Strong promoters can partially overcome these challenges. However, availability of suitable promoters showing strong expression with the desired specificity is often limited. In order to ensure availability of sufficient promoters with desired expression specificity, the identification and characterization of additional promoters can help to close this gap. However, natural availability of promoters of the respective specificity and strength and the time consuming characterization of promoter candidates impedes the identification of suitable new promoters.
- introns have been recognized as genetic elements with a strong potential for improving gene expression. Although the mechanism is largely unknown, it has been shown that some introns positively affect the steady state amount of mature mRNA, possibly by enhanced transcriptional activity, improved mRNA maturation, enhanced nuclear mRNA export and/or improved translation initiation (e.g. Huang and Gorman, 1990; Le Hir et al., 2003; Nott et al., 2004). Since only selected introns were shown to increase expression, splicing as such is likely not accountable for the observed effects.
- intron mediated enhancement of gene expression and has been shown in various monocotyledonous (e.g. Callis et al., 1987; Vasil et al., 1989; Bruce et al., 1990; Lu et al., 2008) and dicotyledonous plants (e.g. Chung et al., 2006; Kim et al., 2006; Rose et al., 2008).
- ATG translational start site
- introns were shown to also affect the tissue specificity in their native nucleotide environment in plants. Reporter gene expression was found to be dependent on the presence of genomic regions containing up to two introns (Sieburth et al., 1997; Wang et al., 2004). 5' UTR introns have also been reported to be of importance for proper functionality of promoter elements, likely due to tissue specific gene control elements residing in the introns (Fu et al.,1995a; Fu et al., 1995b; Vitale et al., 2003; Kim et al., 2006).
- nucleic acid molecules that enhance the expression of said promoters without affecting their specificity upon functionally linkage to constitutive promoters.
- These nucleic acid molecules are in the present application described as "nucleic acid expression enhancing nucleic acids" (NEENA).
- NEENA nucleic acid expression enhancing nucleic acids
- Introns have the intrinsic feature to be spliced out of the respective pre-mRNA.
- the nucleic acids presented in the application at hand do not necessarily have to be included in the mRNA or, if present in the mRNA, have not necessarily to be spliced out of the mRNA in order to enhance the expression derived from the promoter the NEENAs are functionally linked to.
- a first embodiment of the invention comprises a method for production of a high expression constitutive promoter comprising functionally linking to a promoter one or more nucleic acid expression enhancing nucleic acid (NEENA) molecule comprising
- the one or more NEENA is functionally linked to any constitutive promoter and will enhance expression of the nucleic acid molecule under control of said promoter.
- Constitutive promoters to be used in any method of the invention may be derived from plants, for example monocotyledonous or dicotyledonous plants, from bacteria and/or viruses or may be synthetic promoters.
- Constitutive promoters to be used are for example the PcUbi-Promoter from P.
- AtFNR-promoter from the A.thaliana gene At5g66190 encoding the ferredoxin NADH reductase, the ptxA promoter from Pisum sativum ( WO2005085450 ), the AtTPT-promoter from the A.thaliana gene At5g46110 encoding the triose phosphate translocator, the bidirectional AtOASTL-promoter from the A.thaliana genes At4g14880 and At4g14890 , the PRO0194 promoter from the A.thaliana gene At1g13440 encoding the glyceraldehyde-3-phosphate dehydrogenase, the PRO0162 promoter from the A.thaliana gene At3g52930 encoding the fructose-bisphosphate aldolase, the AHAS-promoter ( WO2008124495 ) or the CaffeoylCoA-MT promoter and the OsCP12 from rice ( WO2006084868 ).
- the high expression constitutive promoters of the invention functionally linked to a NEENA may be employed in any plant comprising for example moss, fern, gymnosperm or angiosperm, for example monocotyledonous or dicotyledonous plant.
- said promoter of the invention functionally linked to a NEENA may be employed in monocotyledonous or dicotyledonous plants, preferably crop plant such as corn, soy, canola, cotton, potato, sugar beet, rice, wheat, sorghum, barley, musa, sugarcane, miscanthus and the like.
- said promoter which is functionally linked to a NEENA may be employed in monocotyledonous crop plants such as corn, rice, wheat, sorghum, musa, miscanthus, sugarcane or barley.
- the promoter functionally linked to a NEENA may be employed in dicotyledonous crop plants such as soy, canola, cotton, sugar beet or potato.
- a high expressing constitutive promoter as used in the application means for example a promoter which is functionally linked to a NEENA causing enhanced constitutive expression of the promoter in a plant or part thereof wherein the accumulation of RNA or rate of synthesis of RNA derived from the nucleic acid molecule under the control of the respective promoter functionally linked to a NEENA is higher, preferably significantly higher than the expression caused by the same promoter lacking a NEENA of the invention.
- the amount of RNA of the respective nucleic acid and/or the rate of RNA synthesis and/or the RNA stability in a plant is increased 50% or more, for example 100% or more, preferably 200% or more, more preferably 5 fold or more, even more preferably 10 fold or more, most preferably 20 fold or more for example 50 fold compared to a control plant of same age grown under the same conditions comprising the same constitutive promoter the latter not being functionally linked to a NEENA of the invention.
- telomere length When used herein, significantly higher refers to statistical significance the skilled person is aware how to determine, for example by applying statistical tests such as the t-test to the respective data sets.
- Methods for detecting expression conferred by a promoter are known in the art.
- the promoter may be functionally linked to a marker gene such as GUS, GFP or luciferase and the activity of the respective protein encoded by the respective marker gene may be determined in the plant or part thereof.
- a marker gene such as GUS, GFP or luciferase
- the activity of the respective protein encoded by the respective marker gene may be determined in the plant or part thereof.
- the method for detecting luciferase is described in detail below.
- RNA of the nucleic acid molecule controlled by the promoter are for example measuring the steady state level or synthesis rate of RNA of the nucleic acid molecule controlled by the promoter by methods known in the art, for example Northern blot analysis, qPCR, run-on assays or other methods described in the art.
- a skilled person is aware of various methods for functionally linking two or more nucleic acid molecules. Such methods may encompass restriction/ligation, ligase independent cloning, re-combineering, recombination or synthesis. Other methods may be employed to functionally link two or more nucleic acid molecules.
- a further embodiment of the present invention is a method for producing a plant or part thereof with, compared to a respective control plant or part thereof, enhanced constitutive expression of one or more nucleic acid molecule comprising the steps of introducing into the plant or part thereof one or more NEENA comprising a nucleic acid molecule as defined above under i) to iv) and functionally linking said one or more NEENA to a promoter, preferably a constitutive promoter and to a nucleic acid molecule being under the control of said promoter, preferably constitutive promoter, wherein the NEENA is heterologous to said nucleic acid molecule.
- the NEENA may be heterologous to the nucleic acid molecule which is under the control of said promoter to which the NEENA is functionally linked or it may be heterologous to both the promoter and the nucleic acid molecule under the control of said promoter.
- heterologous with respect to a nucleic acid molecule or DNA refers to a nucleic acid molecule which is operably linked to, or is manipulated to become operably linked to, a second nucleic acid molecule to which it is not operably linked in nature, or to which it is operably linked at a different location in nature.
- a NEENA of the invention is in its natural environment functionally linked to its native promoter, whereas in the present invention it is linked to another promoter which might be derived from the same organism, a different organism or might be a synthetic promoter such as the SUPER-promoter. It may also mean that the NEENA of the present invention is linked to its native promoter but the nucleic acid molecule under control of said promoter is heterologous to the promoter comprising its native NEENA.
- the promoter and/or the nucleic acid molecule under the control of said promoter functionally linked to a NEENA of the invention are heterologous to said NEENA as their sequence has been manipulated by for example mutation such as insertions, deletions and the forth so that the natural sequence of the promoter and/or the nucleic acid molecule under control of said promoter is modified and therefore have become heterologous to a NEENA of the invention.
- the NEENA is heterologous to the nucleic acid to which it is functionally linked when the NEENA is functionally linked to its native promoter wherein the position of the NEENA in relation to said promoter is changed so that the promoter shows higher expression after such manipulation.
- a plant exhibiting enhanced constitutive expression of a nucleic acid molecule as meant herein means a plant having a higher, preferably statistically significant higher constitutive expression of a nucleic acid molecule compared to a control plant grown under the same conditions without the respective NEENA functionally linked to the respective nucleic acid molecule.
- Such control plant may be a wild-type plant or a transgenic plant comprising the same promoter controlling the same gene as in the plant of the invention wherein the promoter is not linked to a NEENA of the invention.
- Producing a plant as used herein comprises methods for stable transformation such as introducing a recombinant DNA construct into a plant or part thereof by means of Agrobacterium mediated transformation, protoplast transformation, particle bombardment or the like and optionally subsequent regeneration of a transgenic plant. It also comprises methods for transient transformation of a plant or part thereof such as viral infection or Agrobacterium infiltration. A skilled person is aware of further methods for stable and/or transient transformation of a plant or part thereof. Approaches such as breeding methods or protoplast fusion might also be employed for production of a plant of the invention and are covered herewith.
- the method of the invention may be applied to any plant, for example gymnosperm or angiosperm, preferably angiosperm, for example dicotyledonous or monocotyledonous plants, preferably dicotyledonous plants.
- Preferred monocotyledonous plants are for example corn, wheat, rice, barley, sorghum, musa, sugarcane, miscanthus and brachypodium, especially preferred monocotyledonous plants are corn, wheat and rice.
- Preferred dicotyledonous plants are for example soy, rape seed, canola, linseed, cotton, potato, sugar beet, tagetes and Arabidopsis, especially preferred dicotyledonous plants are soy, rape seed, canola and potato
- the methods as defined above are comprising the steps of
- a further way to perform the methods of the invention may be to
- said one or more NEENA is functionally linked to a promoter, preferably constitutive promoter close to the transcription start site of said heterologous nucleic acid molecule.
- Close to the transcription start site as meant herein comprises functionally linking one or more NEENA to a promoter, preferably a constitutive promoter 2500 bp or less, preferentially 2000 bp or less, more preferred 1500 bp or less, even more preferred 1000 bp or less and most preferred 500 bp or less away from the transcription start site of said heterologous nucleic acid molecule.
- the NEENA may be integrated upstream or downstream in the respective distance from the transcription start site of the respective promoter.
- the one or more NEENA must not necessarily be included in the transcript of the respective heterologous nucleic acid under control of the preferably constitutive promoter the one or more NEENA is functionally linked to.
- the one or more NEENA is integrated downstream of the transcription start site of the respective promoter, preferably constitutive promoter.
- the integration site downstream of the transcription start site may be in the 5' UTR, the 3' UTR, an exon or intron or it may replace an intron or partially or completely the 5' UTR or 3' UTR of the heterologous nucleic acid under the control of the preferably constitutive promoter.
- the one or more NEENA is integrated in the 5' UTR or an intron or the NEENA is replacing an intron or a part or the complete 5'UTR, most preferentially it is integrated in the 5'UTR of the respective heterologous nucleic acid.
- a further embodiment of the invention comprises a recombinant expression construct comprising one or more NEENA comprising a nucleic acid molecule as defined above in i) to vi).
- the recombinant expression construct may further comprise one or more promoter, preferably constitutive promoter to which the one or more NEENA is functionally linked and optionally one or more expressed nucleic acid molecule the latter being heterologous to said one or more NEENA.
- the NEENA may be heterologous to the nucleic acid molecule which is under the control of said promoter to which the NEENA is functionally linked or it may be heterologous to both the promoter and the nucleic acid molecule under the control of said promoter.
- the expression construct may comprise one ore more, for example two or more, for example 5 or more, such as 10 or more combinations of promoters, preferably constitutive promoters functionally linked to a NEENA and a nucleic acid molecule to be expressed heterologous to the respective NEENA.
- the expression construct may also comprise further promoters not comprising a NEENA functionally linked to nucleic acid molecules to be expressed homologous or heterologous to the respective promoter.
- a recombinant expression vector comprising one or more recombinant expression construct as defined above is another embodiment of the invention.
- a multitude of expression vectors that may be used in the present invention are known to a skilled person.
- Methods for introducing such a vector comprising such an expression construct comprising for example a promoter functionally linked to a NEENA and optionally other elements such as a terminator into the genome of a plant and for recovering transgenic plants from a transformed cell are also well known in the art.
- the entire vector might be integrated into the genome of said plant or part thereof or certain components of the vector might be integrated into the genome, such as, for example a T-DNA.
- a transgenic plant or part thereof comprising one or more heterologous NEENA as defined above in i) to iv) is also enclosed in this invention.
- a NEENA is to be understood as being heterologous to the plant if it is synthetic, derived from another organism or the same organism but its natural genomic localization is rendered compared to a control plant, for example a wild type plant.
- a rendered genomic localization means the NEENA is located on another chromosome or on the same chromosome but 10 kb or more, for example 10 kb, preferably 5 kb or more, for example 5 kb, more preferably 1000 bp or more, for example 1000 bp, even more preferably 500 bp or more, for example 500 bp, especially preferably 100bp or more, for example 100 bp, most preferably 10 bp or more, for example 10 bp dislocated from its natural genomic localization, for example in a wild type plant.
- a transgenic cell or transgenic plant or part thereof comprising a recombinant expression vector as defined above or a recombinant expression construct as defined above is a further embodiment of the invention.
- the transgenic cell, transgenic plant or part thereof may be selected from the group consisting of bacteria, fungi, yeasts or plant, insect or mammalian cells or plants.
- the transgenic cells are bacteria, fungi, yeasts or plant cells.
- Preferred bacteria are Enterobacteria such as E. coli and bacteria of the genus Agrobacteria, for example Agrobacterium tumefaciens and Agrobacterium rhizogenes.
- Preferred plants are monocotyledonous or dicotyledonous plants for example monocotyledonous or dicotyledonous crop plants such as corn, soy, canola, cotton, potato, sugar beet, rice, wheat, sorghum, barley, miscanthus, musa, sugarcane and the like.
- Preferred crop plants are corn, rice, wheat, soy, canola, cotton or potato.
- Especially preferred dicotyledonous crop plants are soy, canola, cotton or potato.
- Especially preferred monocotyledonous crop plants are corn, wheat and rice.
- transgenic cell culture, transgenic seed, parts or propagation material derived from a transgenic cell or plant or part thereof as defined above comprising said heterologous NEENA as defined above in i) to iv) or said recombinant expression construct or said recombinant vector as defined above are other embodiments of the invention.
- Transgenic parts or propagation material as meant herein comprise all tissues and organs, for example leaf, stem and fruit as well as material that is useful for propagation and/or regeneration of plants such as cuttings, scions, layers, branches or shoots comprising the respective NEENA, recombinant expression construct or recombinant vector.
- a further embodiment of the invention is the use of the NEENA as defined above in i) to iv) or the recombinant construct or recombinant vector as defined above for enhancing expression in plants or parts thereof.
- the application at hand provides seed-specific and/or seed-preferential gene expression enhancing nucleic acid molecules comprising one or more promoter, preferably seed- specific and/or seed preferential promoter functionally linked to one ore more NEENA. Additionally use of such gene expression enhancing nucleic acid molecules and expression constructs, expression vectors, transgenic plants or parts thereof and transgenic cells comprising such gene expression enhancing nucleic acid molecules are provided.
- transgenic cell culture A use of a transgenic cell culture, transgenic seed, parts or propagation material derived from a transgenic cell or plant or part thereof as defined above for the production of foodstuffs, animal feeds, seeds, pharmaceuticals or fine chemicals is also enclosed in this invention.
- NEENA nucleic acid expression enhancing nucleic acid
- GFP green fluorescence protein
- GUS beta-Glucuronidase
- BAP 6-benzylaminopurine
- 2,4-D 2,4-dichlorophenoxyacetic acid
- MS Murashige and Skoog medium
- MES 2-(N-morpholino-ethanesulfonic acid, IAA indole acetic acid
- Kan Kanamycin sulfate
- GA3 Gibberellic acid
- TimentinTM ticarcillin disodium / clavulanate potassium
- microl Microliter.
- Antiparallel refers herein to two nucleotide sequences paired through hydrogen bonds between complementary base residues with phosphodiester bonds running in the 5'-3' direction in one nucleotide sequence and in the 3'-5' direction in the other nucleotide sequence.
- Antisense refers to a nucleotide sequence that is inverted relative to its normal orientation for transcription or function and so expresses an RNA transcript that is complementary to a target gene mRNA molecule expressed within the host cell (e.g., it can hybridize to the target gene mRNA molecule or single stranded genomic DNA through Watson-Crick base pairing) or that is complementary to a target DNA molecule such as, for example genomic DNA present in the host cell.
- Coding region when used in reference to a structural gene refers to the nucleotide sequences which encode the amino acids found in the nascent polypeptide as a result of translation of a mRNA molecule.
- the coding region is bounded, in eukaryotes, on the 5'-side by the nucleotide triplet "ATG” which encodes the initiator methionine and on the 3'-side by one of the three triplets which specify stop codons (i.e., TAA, TAG, TGA).
- ATG nucleotide triplet
- genomic forms of a gene may also include sequences located on both the 5'- and 3'-end of the sequences which are present on the RNA transcript.
- flanking sequences or regions are referred to as "flanking" sequences or regions (these flanking sequences are located 5' or 3' to the non-translated sequences present on the mRNA transcript).
- the 5'-flanking region may contain regulatory sequences such as promoters and enhancers which control or influence the transcription of the gene.
- the 3'-flanking region may contain sequences which direct the termination of transcription, post-transcriptional cleavage and polyadenylation.
- Complementary refers to two nucleotide sequences which comprise antiparallel nucleotide sequences capable of pairing with one another (by the base-pairing rules) upon formation of hydrogen bonds between the complementary base residues in the antiparallel nucleotide sequences.
- sequence 5'-AGT-3' is complementary to the sequence 5'-ACT-3'.
- Complementarity can be "partial” or “total.”
- Partial complementarity is where one or more nucleic acid bases are not matched according to the base pairing rules.
- Total or “complete” complementarity between nucleic acid molecules is where each and every nucleic acid base is matched with another base under the base pairing rules.
- a "complement" of a nucleic acid sequence as used herein refers to a nucleotide sequence whose nucleic acid molecules show total complementarity to the nucleic acid molecules of the nucleic acid sequence.
- Double-stranded RNA A "double-stranded RNA” molecule or “dsRNA” molecule comprises a sense RNA fragment of a nucleotide sequence and an antisense RNA fragment of the nucleotide sequence, which both comprise nucleotide sequences complementary to one another, thereby allowing the sense and antisense RNA fragments to pair and form a double-stranded RNA molecule.
- Endogenous nucleotide sequence refers to a nucleotide sequence, which is present in the genome of the untransformed plant cell.
- Enhanced expression “enhance” or “increase” the expression of a nucleic acid molecule in a plant cell are used equivalently herein and mean that the level of expression of the nucleic acid molecule in a plant, part of a plant or plant cell after applying a method of the present invention is higher than its expression in the plant, part of the plant or plant cell before applying the method, or compared to a reference plant lacking a recombinant nucleic acid molecule of the invention.
- the reference plant is comprising the same construct which is only lacking the respective NEENA.
- the term “enhanced” or “increased” as used herein are synonymous and means herein higher, preferably significantly higher expression of the nucleic acid molecule to be expressed.
- an “enhancement” or “increase” of the level of an agent such as a protein, mRNA or RNA means that the level is increased relative to a substantially identical plant, part of a plant or plant cell grown under substantially identical conditions, lacking a recombinant nucleic acid molecule of the invention, for example lacking the NEENA molecule, the recombinant construct or recombinant vector of the invetion.
- “enhancement” or “increase” of the level of an agent means that the level is increased 50% or more, for example 100% or more, preferably 200% or more, more preferably 5 fold or more, even more preferably 10 fold or more, most preferably 20 fold or more for example 50 fold relative to a cell or organism lacking a recombinant nucleic acid molecule of the invention.
- the enhancement or increase can be determined by methods with which the skilled worker is familiar.
- the enhancement or increase of the nucleic acid or protein quantity can be determined for example by an immunological detection of the protein.
- techniques such as protein assay, fluorescence, Northern hybridization, nuclease protection assay, reverse transcription (quantitative RT-PCR), ELISA (enzyme-linked immunosorbent assay), Western blotting, radioimmunoassay (RIA) or other immunoassays and fluorescence-activated cell analysis (FACS) can be employed to measure a specific protein or RNA in a plant or plant cell.
- RIA radioimmunoassay
- FACS fluorescence-activated cell analysis
- Methods for determining the protein quantity are known to the skilled worker.
- Expression refers to the biosynthesis of a gene product, preferably to the transcription and/or translation of a nucleotide sequence, for example an endogenous gene or a heterologous gene, in a cell.
- expression involves transcription of the structural gene into mRNA and - optionally - the subsequent translation of mRNA into one or more polypeptides. In other cases, expression may refer only to the transcription of the DNA harboring an RNA molecule.
- Expression construct as used herein mean a DNA sequence capable of directing expression of a particular nucleotide sequence in an appropriate part of a plant or plant cell, comprising a promoter functional in said part of a plant or plant cell into which it will be introduced, operatively linked to the nucleotide sequence of interest which is - optionally - operatively linked to termination signals. If translation is required, it also typically comprises sequences required for proper translation of the nucleotide sequence.
- the coding region may code for a protein of interest but may also code for a functional RNA of interest, for example RNAa, siRNA, snoRNA, snRNA, microRNA, ta-siRNA or any other noncoding regulatory RNA, in the sense or antisense direction.
- the expression construct comprising the nucleotide sequence of interest may be chimeric, meaning that one or more of its components is heterologous with respect to one or more of its other components.
- the expression construct may also be one, which is naturally occurring but has been obtained in a recombinant form useful for heterologous expression.
- the expression construct is heterologous with respect to the host, i.e., the particular DNA sequence of the expression construct does not occur naturally in the host cell and must have been introduced into the host cell or an ancestor of the host cell by a transformation event.
- the expression of the nucleotide sequence in the expression construct may be under the control of a constitutive promoter or of an inducible promoter, which initiates transcription only when the host cell is exposed to some particular external stimulus.
- the promoter can also be specific to a particular tissue or organ or stage of development.
- Foreign refers to any nucleic acid molecule (e.g., gene sequence) which is introduced into the genome of a cell by experimental manipulations and may include sequences found in that cell so long as the introduced sequence contains some modification (e.g., a point mutation, the presence of a selectable marker gene, etc.) and is therefore distinct relative to the naturally-occurring sequence.
- nucleic acid molecule e.g., gene sequence
- some modification e.g., a point mutation, the presence of a selectable marker gene, etc.
- Functional linkage is to be understood as meaning, for example, the sequential arrangement of a regulatory element (e.g. a promoter) with a nucleic acid sequence to be expressed and, if appropriate, further regulatory elements (such as e.g., a terminator or a NEENA) in such a way that each of the regulatory elements can fulfill its intended function to allow, modify, facilitate or otherwise influence expression of said nucleic acid sequence.
- a regulatory element e.g. a promoter
- further regulatory elements such as e.g., a terminator or a NEENA
- operble linkage or “operably linked” may be used.
- the expression may result depending on the arrangement of the nucleic acid sequences in relation to sense or antisense RNA. To this end, direct linkage in the chemical sense is not necessarily required.
- Genetic control sequences such as, for example, enhancer sequences, can also exert their function on the target sequence from positions which are further away, or indeed from other DNA molecules.
- Preferred arrangements are those in which the nucleic acid sequence to be expressed recombinantly is positioned behind the sequence acting as promoter, so that the two sequences are linked covalently to each other.
- the distance between the promoter sequence and the nucleic acid sequence to be expressed recombinantly is preferably less than 200 base pairs, especially preferably less than 100 base pairs, very especially preferably less than 50 base pairs.
- the nucleic acid sequence to be transcribed is located behind the promoter in such a way that the transcription start is identical with the desired beginning of the chimeric RNA of the invention.
- sequences which, for example, act as a linker with specific cleavage sites for restriction enzymes, or as a signal peptide, may also be positioned between the two sequences.
- the insertion of sequences may also lead to the expression of fusion proteins.
- the expression construct consisting of a linkage of a regulatory region for example a promoter and nucleic acid sequence to be expressed, can exist in a vector-integrated form and be inserted into a plant genome, for example by transformation.
- Gene refers to a region operably joined to appropriate regulatory sequences capable of regulating the expression of the gene product (e.g., a polypeptide or a functional RNA) in some manner.
- a gene includes untranslated regulatory regions of DNA (e.g., promoters, enhancers, repressors, etc.) preceding (up-stream) and following (downstream) the coding region (open reading frame, ORF) as well as, where applicable, intervening sequences (i.e., introns) between individual coding regions (i.e., exons).
- constructural gene as used herein is intended to mean a DNA sequence that is transcribed into mRNA which is then translated into a sequence of amino acids characteristic of a specific polypeptide.
- Genome and genomic DNA are referring to the heritable genetic information of a host organism.
- Said genomic DNA comprises the DNA of the nucleus (also referred to as chromosomal DNA) but also the DNA of the plastids (e.g., chloroplasts) and other cellular organelles (e.g., mitochondria).
- the terms genome or genomic DNA is referring to the chromosomal DNA of the nucleus.
- heterologous refers to a nucleic acid molecule which is operably linked to, or is manipulated to become operably linked to, a second nucleic acid molecule to which it is not operably linked in nature, or to which it is operably linked at a different location in nature.
- a heterologous expression construct comprising a nucleic acid molecule and one or more regulatory nucleic acid molecule (such as a promoter or a transcription termination signal) linked thereto for example is a constructs originating by experimental manipulations in which either a) said nucleic acid molecule, or b) said regulatory nucleic acid molecule or c) both (i.e.
- Natural genetic environment refers to the natural chromosomal locus in the organism of origin, or to the presence in a genomic library.
- the natural genetic environment of the sequence of the nucleic acid molecule is preferably retained, at least in part.
- the environment flanks the nucleic acid sequence at least at one side and has a sequence of at least 50 bp, preferably at least 500 bp, especially preferably at least 1,000 bp, very especially preferably at least 5,000 bp, in length.
- a protein encoding nucleic acid molecule operably linked to a promoter which is not the native promoter of this molecule, is considered to be heterologous with respect to the promoter.
- heterologous DNA is not endogenous to or not naturally associated with the cell into which it is introduced, but has been obtained from another cell or has been synthesized.
- Heterologous DNA also includes an endogenous DNA sequence, which contains some modification, non-naturally occurring, multiple copies of an endogenous DNA sequence, or a DNA sequence which is not naturally associated with another DNA sequence physically linked thereto.
- heterologous DNA encodes RNA or proteins that are not normally produced by the cell into which it is expressed.
- a "high expression constitutive promoter” as used herein means a promoter causing constitutive expression in a plant or part thereof wherein the accumulation or rate of synthesis of RNA or stability of RNA derived from the nucleic acid molecule under the control of the respective promoter is higher, preferably significantly higher than the expression caused by the promoter lacking the NEENA of the invention.
- the amount of RNA and/or the rate of RNA synthesis and/or stability of RNA is increased 50% or more, for example 100% or more, preferably 200% or more, more preferably 5 fold or more, even more preferably 10 fold or more, most preferably 20 fold or more for example 50 fold relative to a constitutive promoter lacking a NEENA of the invention.
- Hybridization includes "any process by which a strand of nucleic acid molecule joins with a complementary strand through base pairing.” ( J. Coombs (1994) Dictionary of Biotechnology, Stockton Press, New York ). Hybridization and the strength of hybridization (i.e., the strength of the association between the nucleic acid molecules) is impacted by such factors as the degree of complementarity between the nucleic acid molecules, stringency of the conditions involved, the Tm of the formed hybrid, and the G:C ratio within the nucleic acid molecules.
- Tm is used in reference to the "melting temperature.”
- the melting temperature is the temperature at which a population of double-stranded nucleic acid molecules becomes half dissociated into single strands.
- Identity when used in respect to the comparison of two or more nucleic acid or amino acid molecules means that the sequences of said molecules share a certain degree of sequence similarity, the sequences being partially identical.
- percentage identity herein used interchangeably
- the sequences are written one underneath the other for an optimal comparison (for example gaps may be inserted into the sequence of a protein or of a nucleic acid in order to generate an optimal alignment with the other protein or the other nucleic acid).
- amino acid residues or nucleic acid molecules at the corresponding amino acid positions or nucleotide positions are then compared. If a position in one sequence is occupied by the same amino acid residue or the same nucleic acid molecule as the corresponding position in the other sequence, the molecules are homologous at this position (i.e. amino acid or nucleic acid "homology” as used in the present context corresponds to amino acid or nucleic acid "identity”.
- Results of high quality are reached by using the algorithm of Needleman and Wunsch or Smith and Waterman. Therefore programs based on said algorithms are preferred.
- the comparisons of sequences can be done with the program PileUp (J. Mol. Evolution., 25, 351 (1987 ), Higgins et al., CABIOS 5, 151 (1989 )) or preferably with the programs "Gap” and “Needle”, which are both based on the algorithms of Needleman and Wunsch (J. Mol. Biol. 48; 443 (1970 )), and "BestFit", which is based on the algorithm of Smith and Waterman (Adv. Appl. Math. 2; 482 (1981 )).
- Gap and “BestFit” are part of the GCG software-package (Genetics Computer Group, 575 Science Drive, Madison, Wisconsin, USA 53711 (1991); Altschul et al., (Nucleic Acids Res. 25, 3389 (1997 )), "Needle” is part of the The European Molecular Biology Open Software Suite (EMBOSS) (Trends in Genetics 16 (6), 276 (2000 )). Therefore preferably the calculations to determine the percentages of sequence identity are done with the programs "Gap” or “Needle” over the whole range of the sequences.
- EMBOSS European Molecular Biology Open Software Suite
- sequence SEQ ID NO: 1 For example a sequence, which is said to have 80% identity with sequence SEQ ID NO: 1 at the nucleic acid level is understood as meaning a sequence which, upon comparison with the sequence represented by SEQ ID NO: 1 by the above program "Needle" with the above parameter set, has a 80% identity.
- the identity is calculated on the complete length of the query sequence, for example SEQ ID NO:1.
- Intron refers to sections of DNA (intervening sequences) within a gene that do not encode part of the protein that the gene produces, and that is spliced out of the mRNA that is transcribed from the gene before it is exported from the cell nucleus.
- Intron sequence refers to the nucleic acid sequence of an intron.
- introns are those regions of DNA sequences that are transcribed along with the coding sequence (exons) but are removed during the formation of mature mRNA. Introns can be positioned within the actual coding region or in either the 5' or 3' untranslated leaders of the pre-mRNA (unspliced mRNA).
- Introns in the primary transcript are excised and the coding sequences are simultaneously and precisely ligated to form the mature mRNA.
- the junctions of introns and exons form the splice site.
- the sequence of an intron begins with GU and ends with AG.
- two examples of AU-AC introns have been described: the fourteenth intron of the RecA-like protein gene and the seventh intron of the G5 gene from Arabidopsis thaliana are AT-AC introns.
- Pre-mRNAs containing introns have three short sequences that are -beside other sequences- essential for the intron to be accurately spliced. These sequences are the 5' splice-site, the 3' splice-site, and the branchpoint.
- mRNA splicing is the removal of intervening sequences (introns) present in primary mRNA transcripts and joining or ligation of exon sequences. This is also known as cis-splicing which joins two exons on the same RNA with the removal of the intervening sequence (intron).
- the functional elements of an intron is comprising sequences that are recognized and bound by the specific protein components of the spliceosome (e.g. splicing consensus sequences at the ends of introns). The interaction of the functional elements with the spliceosome results in the removal of the intron sequence from the premature mRNA and the rejoining of the exon sequences.
- Introns have three short sequences that are essential -although not sufficient- for the intron to be accurately spliced. These sequences are the 5' splice site, the 3' splice site and the branch point.
- the branchpoint sequence is important in splicing and splice-site selection in plants.
- the branchpoint sequence is usually located 10-60 nucleotides upstream of the 3' splice site.
- Isogenic organisms (e.g., plants), which are genetically identical, except that they may differ by the presence or absence of a heterologous DNA sequence.
- Isolated means that a material has been removed by the hand of man and exists apart from its original, native environment and is therefore not a product of nature.
- An isolated material or molecule (such as a DNA molecule or enzyme) may exist in a purified form or may exist in a non-native environment such as, for example, in a transgenic host cell.
- a naturally occurring polynucleotide or polypeptide present in a living plant is not isolated, but the same polynucleotide or polypeptide, separated from some or all of the coexisting materials in the natural system, is isolated.
- Such polynucleotides can be part of a vector and/or such polynucleotides or polypeptides could be part of a composition, and would be isolated in that such a vector or composition is not part of its original environment.
- isolated when used in relation to a nucleic acid molecule, as in "an isolated nucleic acid sequence” refers to a nucleic acid sequence that is identified and separated from at least one contaminant nucleic acid molecule with which it is ordinarily associated in its natural source. Isolated nucleic acid molecule is nucleic acid molecule present in a form or setting that is different from that in which it is found in nature.
- non-isolated nucleic acid molecules are nucleic acid molecules such as DNA and RNA, which are found in the state they exist in nature.
- a given DNA sequence e.g., a gene
- RNA sequences such as a specific mRNA sequence encoding a specific protein, are found in the cell as a mixture with numerous other mRNAs, which encode a multitude of proteins.
- an isolated nucleic acid sequence comprising for example SEQ ID NO: 1 includes, by way of example, such nucleic acid sequences in cells which ordinarily contain SEQ ID NO:1 where the nucleic acid sequence is in a chromosomal or extrachromosomal location different from that of natural cells, or is otherwise flanked by a different nucleic acid sequence than that found in nature.
- the isolated nucleic acid sequence may be present in single-stranded or double-stranded form.
- the nucleic acid sequence will contain at a minimum at least a portion of the sense or coding strand (i.e., the nucleic acid sequence may be single-stranded). Alternatively, it may contain both the sense and anti-sense strands (i.e., the nucleic acid sequence may be double-stranded).
- Minimal Promoter promoter elements, particularly a TATA element, that are inactive or that have greatly reduced promoter activity in the absence of upstream activation. In the presence of a suitable transcription factor, the minimal promoter functions to permit transcription.
- NEENA see "Nucleic acid expression enhancing nucleic acid”.
- Non-coding refers to sequences of nucleic acid molecules that do not encode part or all of an expressed protein. Non-coding sequences include but are not limited to introns, enhancers, promoter regions, 3' untranslated regions, and 5' untranslated regions.
- Nucleic acid expression enhancing nucleic acid refers to a sequence and/or a nucleic acid molecule of a specific sequence having the intrinsic property to enhance expression of a nucleic acid under the control of a promoter to which the NEENA is functionally linked. Unlike promoter sequences, the NEENA as such is not able to drive expression. In order to fulfill the function of enhancing expression of a nucleic acid molecule functionally linked to the NEENA, the NEENA itself has to be functionally linked to a promoter. In distinction to enhancer sequences known in the art, the NEENA is acting in cis but not in trans and has to be located close to the transcription start site of the nucleic acid to be expressed.
- Nucleic acids and nucleotides refer to naturally occurring or synthetic or artificial nucleic acid or nucleotides.
- nucleic acids and “nucleotides” comprise deoxyribonucleotides or ribonucleotides or any nucleotide analogue and polymers or hybrids thereof in either single- or double-stranded, sense or antisense form.
- a particular nucleic acid sequence also implicitly encompasses conservatively modified variants thereof (e.g., degenerate codon substitutions) and complementary sequences, as well as the sequence explicitly indicated.
- nucleic acid is used interchangeably herein with “gene”, “cDNA, “mRNA”, “oligonucleotide,” and “polynucleotide”.
- Nucleotide analogues include nucleotides having modifications in the chemical structure of the base, sugar and/or phosphate, including, but not limited to, 5-position pyrimidine modifications, 8-position purine modifications, modifications at cytosine exocyclic amines, substitution of 5-bromo-uracil, and the like; and 2'-position sugar modifications, including but not limited to, sugar-modified ribonucleotides in which the 2'-OH is replaced by a group selected from H, OR, R, halo, SH, SR, NH2, NHR, NR2, or CN.
- Short hairpin RNAs also can comprise non-natural elements such as non-natural bases, e.g., ionosin and xanthine, non-natural sugars, e.g., 2'-methoxy ribose, or non-natural phosphodiester linkages, e.g., methylphosphonates, phosphorothioates and peptides.
- non-natural bases e.g., ionosin and xanthine
- non-natural sugars e.g., 2'-methoxy ribose
- non-natural phosphodiester linkages e.g., methylphosphonates, phosphorothioates and peptides.
- nucleic acid sequence refers to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5'- to the 3'-end. It includes chromosomal DNA, self-replicating plasmids, infectious polymers of DNA or RNA and DNA or RNA that performs a primarily structural role. "Nucleic acid sequence” also refers to a consecutive list of abbreviations, letters, characters or words, which represent nucleotides.
- a nucleic acid can be a "probe” which is a relatively short nucleic acid, usually less than 100 nucleotides in length.
- nucleic acid probe is from about 50 nucleotides in length to about 10 nucleotides in length.
- a "target region” of a nucleic acid is a portion of a nucleic acid that is identified to be of interest.
- a “coding region” of a nucleic acid is the portion of the nucleic acid, which is transcribed and translated in a sequence-specific manner to produce into a particular polypeptide or protein when placed under the control of appropriate regulatory sequences. The coding region is said to encode such a polypeptide or protein.
- Oligonucleotide refers to an oligomer or polymer of ribonucleic acid (RNA) or deoxyribonucleic acid (DNA) or mimetics thereof, as well as oligonucleotides having non-naturally-occurring portions which function similarly. Such modified or substituted oligonucleotides are often preferred over native forms because of desirable properties such as, for example, enhanced cellular uptake, enhanced affinity for nucleic acid target and increased stability in the presence of nucleases.
- An oligonucleotide preferably includes two or more nucleomonomers covalently coupled to each other by linkages (e.g., phosphodiesters) or substitute linkages.
- Overhang is a relatively short single-stranded nucleotide sequence on the 5'- or 3'-hydroxyl end of a double-stranded oligonucleotide molecule (also referred to as an "extension,” “protruding end,” or “sticky end”).
- Plant is generally understood as meaning any eukaryotic single-or multi-celled organism or a cell, tissue, organ, part or propagation material (such as seeds or fruit) of same which is capable of photosynthesis. Included for the purpose of the invention are all genera and species of higher and lower plants of the Plant Kingdom. Annual, perennial, monocotyledonous and dicotyledonous plants are preferred. The term includes the mature plants, seed, shoots and seedlings and their derived parts, propagation material (such as seeds or microspores), plant organs, tissue, protoplasts, callus and other cultures, for example cell cultures, and any other type of plant cell grouping to give functional or structural units. Mature plants refer to plants at any desired developmental stage beyond that of the seedling.
- Seedling refers to a young immature plant at an early developmental stage. Annual, biennial, monocotyledonous and dicotyledonous plants are preferred host organisms for the generation of transgenic plants. The expression of genes is furthermore advantageous in all ornamental plants, useful or ornamental trees, flowers, cut flowers, shrubs or lawns.
- Plants which may be mentioned by way of example but not by limitation are angiosperms, bryophytes such as, for example, Hepaticae (liverworts) and Musci (mosses); Pteridophytes such as ferns, horsetail and club mosses; gymnosperms such as conifers, cycads, ginkgo and Gnetatae; algae such as Chlorophyceae, Phaeophpyceae, Rhodophyceae, Myxophyceae, Xanthophyceae, Bacillariophyceae (diatoms), and Euglenophyceae.
- angiosperms bryophytes such as, for example, Hepaticae (liverworts) and Musci (mosses); Pteridophytes such as ferns, horsetail and club mosses; gymnosperms such as conifers, cycads, ginkgo and Gnetatae; algae such as Ch
- Preferred are plants which are used for food or feed purpose such as the families of the Leguminosae such as pea, alfalfa and soya; Gramineae such as rice, maize, wheat, barley, sorghum, millet, rye, triticale, or oats; the family of the Umbelliferae, especially the genus Daucus, very especially the species carota (carrot) and Apium, very especially the species Graveolens dulce (celery) and many others; the family of the Solanaceae, especially the genus Lycopersicon, very especially the species esculentum (tomato) and the genus Solanum, very especially the species tuberosum (potato) and melongena (egg plant), and many others (such as tobacco); and the genus Capsicum, very especially the species annuum (peppers) and many others; the family of the Leguminosae, especially the genus Glycine, very especially the
- Polypeptide The terms “polypeptide”, “peptide”, “oligopeptide”, “polypeptide”, “gene product”, “expression product” and “protein” are used interchangeably herein to refer to a polymer or oligomer of consecutive amino acid residues.
- Pre-protein Protein, which is normally targeted to a cellular organelle, such as a chloroplast, and still comprising its transit peptide.
- Primary transcript refers to a premature RNA transcript of a gene.
- a “primary transcript” for example still comprises introns and/or is not yet comprising a polyA tail or a cap structure and/or is missing other modifications necessary for its correct function as transcript such as for example trimming or editing.
- promoter refers to a DNA sequence which when ligated to a nucleotide sequence of interest is capable of controlling the transcription of the nucleotide sequence of interest into RNA.
- a promoter is located 5' (i.e., upstream), proximal to the transcriptional start site of a nucleotide sequence of interest whose transcription into mRNA it controls, and provides a site for specific binding by RNA polymerase and other transcription factors for initiation of transcription.
- Said promoter comprises for example the at least 10 kb, for example 5 kb or 2 kb proximal to the transcription start site. It may also comprise the at least 1500 bp proximal to the transcriptional start site, preferably the at least 1000 bp, more preferably the at least 500 bp, even more preferably the at least 400 bp, the at least 300 bp, the at least 200 bp or the at least 100 bp.
- the promoter comprises the at least 50 bp proximal to the transcription start site, for example, at least 25 bp.
- the promoter does not comprise exon and/or intron regions or 5' untranslated regions.
- the promoter may for example be heterologous or homologous to the respective plant.
- a polynucleotide sequence is "heterologous to" an organism or a second polynucleotide sequence if it originates from a foreign species, or, if from the same species, is modified from its original form.
- a promoter operably linked to a heterologous coding sequence refers to a coding sequence from a species different from that from which the promoter was derived, or, if from the same species, a coding sequence which is not naturally associated with the promoter (e.g. a genetically engineered coding sequence or an allele from a different ecotype or variety).
- Suitable promoters can be derived from genes of the host cells where expression should occur or from pathogens for this host cells (e.g., plants or plant pathogens like plant viruses).
- a plant specific promoter is a promoter suitable for regulating expression in a plant. It may be derived from a plant but also from plant pathogens or it might be a synthetic promoter designed by man.
- tissue specific refers to a promoter that is capable of directing selective expression of a nucleotide sequence of interest to a specific type of tissue (e.g., petals) in the relative absence of expression of the same nucleotide sequence of interest in a different type of tissue (e.g., roots).
- Tissue specificity of a promoter may be evaluated by, for example, operably linking a reporter gene to the promoter sequence to generate a reporter construct, introducing the reporter construct into the genome of a plant such that the reporter construct is integrated into every tissue of the resulting transgenic plant, and detecting the expression of the reporter gene (e.g., detecting mRNA, protein, or the activity of a protein encoded by the reporter gene) in different tissues of the transgenic plant.
- the detection of a greater level of expression of the reporter gene in one or more tissues relative to the level of expression of the reporter gene in other tissues shows that the promoter is specific for the tissues in which greater levels of expression are detected.
- cell type specific refers to a promoter, which is capable of directing selective expression of a nucleotide sequence of interest in a specific type of cell in the relative absence of expression of the same nucleotide sequence of interest in a different type of cell within the same tissue.
- the term "cell type specific” when applied to a promoter also means a promoter capable of promoting selective expression of a nucleotide sequence of interest in a region within a single tissue. Cell type specificity of a promoter may be assessed using methods well known in the art, e.g., GUS activity staining, GFP protein or im-munohistochemical staining.
- constitutive when made in reference to a promoter or the expression derived from a promoter means that the promoter is capable of directing transcription of an operably linked nucleic acid molecule in the absence of a stimulus (e.g., heat shock, chemicals, light, etc.) in the majority of plant tissues and cells throughout substantially the entire lifespan of a plant or part of a plant.
- constitutive promoters are capable of directing expression of a transgene in substantially any cell and any tissue.
- promoter specificity when referring to a promoter means the pattern of expression conferred by the respective promoter.
- the specificity describes the tissues and/or developmental status of a plant or part thereof, in which the promoter is conferring expression of the nucleic acid molecule under the control of the respective promoter.
- Specificity of a promoter may also comprise the environmental conditions, under which the promoter may be activated or down-regulated such as induction or repression by biological or environmental stresses such as cold, drought, wounding or infection.
- purified refers to molecules, either nucleic or amino acid sequences that are removed from their natural environment, isolated or separated. “Substantially purified” molecules are at least 60% free, preferably at least 75% free, and more preferably at least 90% free from other components with which they are naturally associated.
- a purified nucleic acid sequence may be an isolated nucleic acid sequence.
- Recombinant refers to nucleic acid molecules produced by recombinant DNA techniques.
- Recombinant nucleic acid molecules may also comprise molecules, which as such does not exist in nature but are modified, changed, mutated or otherwise manipulated by man.
- a "recombinant nucleic acid molecule” is a non-naturally occurring nucleic acid molecule that differs in sequence from a naturally occurring nucleic acid molecule by at least one nucleic acid.
- a “recombinant nucleic acid molecule” may also comprise a "recombinant construct” which comprises, preferably operably linked, a sequence of nucleic acid molecules not naturally occurring in that order.
- Preferred methods for producing said recombinant nucleic acid molecule may comprise cloning techniques, directed or non-directed mutagenesis, synthesis or recombination techniques.
- Sense is understood to mean a nucleic acid molecule having a sequence which is complementary or identical to a target sequence, for example a sequence which binds to a protein transcription factor and which is involved in the expression of a given gene.
- the nucleic acid molecule comprises a gene of interest and elements allowing the expression of the said gene of interest.
- an increase or decrease for example in enzymatic activity or in gene expression, that is larger than the margin of error inherent in the measurement technique, preferably an increase or decrease by about 2-fold or greater of the activity of the control enzyme or expression in the control cell, more preferably an increase or decrease by about 5-fold or greater, and most preferably an increase or decrease by about 10-fold or greater.
- Small nucleic acid molecules are understood as molecules consisting of nucleic acids or derivatives thereof such as RNA or DNA. They may be double-stranded or single-stranded and are between about 15 and about 30 bp, for example between 15 and 30 bp, more preferred between about 19 and about 26 bp, for example between 19 and 26 bp, even more preferred between about 20 and about 25 bp for example between 20 and 25 bp.
- the oligonucleotides are between about 21 and about 24 bp, for example between 21 and 24 bp.
- the small nucleic acid molecules are about 21 bp and about 24 bp, for example 21 bp and 24 bp.
- substantially complementary when used herein with respect to a nucleotide sequence in relation to a reference or target nucleotide sequence, means a nucleotide sequence having a percentage of identity between the substantially complementary nucleotide sequence and the exact complementary sequence of said reference or target nucleotide sequence of at least 60%, more desirably at least 70%, more desirably at least 80% or 85%, preferably at least 90%, more preferably at least 93%, still more preferably at least 95% or 96%, yet still more preferably at least 97% or 98%, yet still more preferably at least 99% or most preferably 100% (the later being equivalent to the term "identical" in this context).
- identity is assessed over a length of at least 19 nucleotides, preferably at least 50 nucleotides, more preferably the entire length of the nucleic acid sequence to said reference sequence (if not specified otherwise below). Sequence comparisons are carried out using default GAP analysis with the University of Wisconsin GCG, SEQWEB application of GAP, based on the algorithm of Needleman and Wunsch ( Needleman and Wunsch (1970) J Mol. Biol. 48: 443-453 ; as defined above). A nucleotide sequence "substantially complementary" to a reference nucleotide sequence hybridizes to the reference nucleotide sequence under low stringency conditions, preferably medium stringency conditions, most preferably high stringency conditions (as defined above).
- transgene refers to any nucleic acid sequence, which is introduced into the genome of a cell by experimental manipulations.
- a transgene may be an "endogenous DNA sequence," or a “heterologous DNA sequence” (i.e., “foreign DNA”).
- endogenous DNA sequence refers to a nucleotide sequence, which is naturally found in the cell into which it is introduced so long as it does not contain some modification (e.g., a point mutation, the presence of a selectable marker gene, etc.) relative to the naturally-occurring sequence.
- transgenic when referring to an organism means transformed, preferably stably transformed, with a recombinant DNA molecule that preferably comprises a suitable promoter operatively linked to a DNA sequence of interest.
- Vector refers to a nucleic acid molecule capable of transporting another nucleic acid molecule to which it has been linked.
- a genomic integrated vector or "integrated vector” which can become integrated into the chromosomal DNA of the host cell.
- Another type of vector is an episomal vector, i.e., a nucleic acid molecule capable of extra-chromosomal replication.
- Vectors capable of directing the expression of genes to which they are operatively linked are referred to herein as "expression vectors”.
- expression vectors vectors capable of directing the expression of genes to which they are operatively linked.
- Expression vectors designed to produce RNAs as described herein in vitro or in vivo may contain sequences recognized by any RNA polymerase, including mitochondrial RNA polymerase, RNA pol I, RNA pol II, and RNA pol III. These vectors can be used to transcribe the desired RNA molecule in the cell according to this invention.
- a plant transformation vector is to be understood as a vector suitable in the process of plant transformation.
- Wild-type The term “wild-type”, “natural” or “natural origin” means with respect to an organism, polypeptide, or nucleic acid sequence, that said organism is naturally occurring or available in at least one naturally occurring organism which is not changed, mutated, or otherwise manipulated by man.
- cloning procedures carried out for the purposes of the present invention including restriction digest, agarose gel electrophoresis, purification of nucleic acids, Ligation of nucleic acids, transformation, selection and cultivation of bacterial cells were performed as described (Sambrook et al., 1989). Sequence analyses of recombinant DNA were performed with a laser fluorescence DNA sequencer (Applied Biosystems, Foster City, CA, USA) using the Sanger technology (Sanger et al., 1977). Unless described otherwise, chemicals and reagents were obtained from Sigma Aldrich (Sigma Aldrich, St.
- NEENAc constitutive NEENA candidates
- Genomic DNA was extracted from A. thaliana green tissue using the Qiagen DNeasy Plant Mini Kit (Qiagen, Hilden, Germany).
- DNA of the vector construct 1bxPcUbi4-2GUS ( WO 2003102198 ) was used.
- Genomic DNA fragments containing putative NEENA molecules were isolated by conventional polymerase chain reaction (PCR).
- the polymerase chain reaction comprised 19 sets of primers (Table 2). Primers were designed on the basis of the A. thaliana genome sequence with a multitude of NEENA candidates.
- the nucleotide sequence of the vector construct 1bxPcUbi4-2GUS was used for the design of primers (SEQ ID NO56 and 57) for amplification of the NEENA candidate with SEQ ID NO1 (Table 2).
- the polymerase chain reaction followed the protocol outlined by Phusion High Fidelity DNA Polymerase (Cat No F-540L, New England Biolabs, Ipswich, MA, USA).
- the isolated DNA was used as template DNA in a PCR amplification using the following primers: Table 2: Primer sequences Primer name Sequence SEQ ID NO PCR yielding SEQ ID NO NEENAc1_for tttatggtaccagccgcaagactcctttcagattct 20 7 NEENAc1_rev aaattccatggtagctgtcaaaacaaaacaaaatcga 21 NEENAc2_for aaaaggtacctcgaagaaccaaaaccaaaaaacgtga 22 10 NEENAc2_rev tttttccatggttatttatccaaaatcccacgatccaaattcca 23 NEENAc4_for ttttggtaccgatccctacttctctcgacact 24 12 NEENAc4_rev ttttaccatggtgactggaggatcaa
- a touch-down approach was employed for the PCR with the following parameters: 98,0°C for 30 sec (1 cycle), 98,0°C for 30 sec, 56,0°C for 30 sec and 72,0°C for 60 sec (4 cycles), 4 additional cycles each for 54,0°C, 51,0°C and 49,0°C annealing temperature, followed by 20 cycles with 98,0°C for 30 sec, 46,0°C for 30 sec and 72,0°C for 60 sec (4 cycles) and 72,0°C for 5 min.
- the amplification products was loaded on a 2 % (w/v) agarose gel and separated at 80V.
- the PCR products were excised from the gel and purified with the Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany). Following a DNA restriction digest with KpnI (10 U/microl) and NcoI (10 U/microl) or EcoRV (10U/microl) restriction endonuclease, the digested products were again purified with the Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany).
- the promoter::NEENA::reporter-gene cassettes were assembled into binary constructs for plant transformation.
- the A. thaliana p-AtNit1 (At3g44310, GenBank X86454; WO03008596 , with the prefix p- denoting promoter) promoter was used in the reporter gene construct, and firefly luciferase (Promega, Madison, WI, USA) was utilized as reporter protein for quantitatively determining the expression enhancing effects of the putative NEENA molecules to be analyzed.
- the pENTR/A vector holding the p-AtNit1 promoter was cloned via site specific recombination (BP-reaction) between the pDONR/A vector and p-AtNit1 amplification products with primers p-AtNit1-for and p-AtNit1-rev (Table 3) on genomic DNA (see above) with site specific recombination sites at either end according to the manufacturers manual (Invitrogen, Carlsbad, CA, USA). Positive pENTR/A clones underwent sequence analysis to ensure correctness of the p-AtNit1 promoter.
- Table 3 Primer sequences (p-AtNit1) Primer name Sequence SEQ ID NO.
- the pENTR/C vector was constructed by introduction of a multiple cloning site (SEQ ID NO60) via KpnI and HindIII restriction sites. By performing a site specific recombination (LR-reaction), the created pENTR/A, pENTR/B and pENTR/C were combined with the pSUN destination vector (pSUN derivative) according to the manufacturers (Invitrogen, Carlsbad, CA, USA) Multisite Gateway manual.
- the reactions yielded 1 binary vector with p-AtNit1 promoter, the firefly luciferase coding sequence c-LUC and the t-nos terminator and 19 vectors harboring SEQ ID NO1, NO2, NO3, NO4, NO5, NO6, NO7, NO8, NO9, NO10, NO11, NO12, NO13, NO14, NO15, NO16, NO17, NO18 and NO19 immediately upstream of the firefly luciferase coding sequence (Table 5), for which the combination with SEQ ID NO1 is given exemplary (SEQ ID NO61). Except for varying SEQ ID NO2 to NO19, the nucleotide sequence is identical in all vectors (Table 5).
- Table 5 Plant expression vectors for A. thaliana transformation plant expression vector Composition of the expression cassette Promoter::SEQ ID NO::reporter gene::terminator SEQ ID NO LJK132 p-AtNit1::-::c-LUC::t-nos LJK133 p-AtNit1::SEQ ID NO1::c-LUC::t-nos 61 LJK91 p-AtNit1::SEQ ID NO7::c-LUC::t-nos LJK92 p-AtNit1::SEQ ID NO10::c-LUC::t-nos LJK94 p-AtNit1::SEQ ID NO12::c-LUC::t-nos LJK95 p-AtNit1::SEQ ID NO3:c-LUC::t-nos LJK97 p-AtNit1::SEQ ID NO
- the resulting vectors were subsequently used to transform A. thaliana leaf protoplasts transiently.
- Renilla luciferase cDNA was amplified using 10ng of the plasmid pRL-null from Promega (Madison, WI, USA) as DNA template and primers R-LUC_for and R-LUC_rev (Table 6) with PCR parameters as described above.
- Table 6 Primer sequences (c-RLUC) Primer name Sequence SEQ ID NO RLUC_for aaaaaggtaccatgacttcgaaagtttatgatc 62 RLUC_rev aaattgagctcttattgttcatttttgagaactc 63
- Example 2 Screening for NEENA candidate molecules enhancing gene expression in A. thaliana transiently transformed leaf protoplasts
- Renilla luciferase (Dual-Luciferase® Reporter Assay System, Promega, Madison, WI, USA) was used to normalize the firefly luciferase expression capabilities of the constructs above.
- Transfected A. thaliana protoplasts were collected by centrifugation at 100 g and frozen in liquid nitrogen after removal of supernatant.
- the assay for detection of firefly and Renilla luciferase activity in the transfected cells was performed according to the manufacturers (Promega, Madison, WI, USA) Dual-Luciferase Reporter Assay System manual. Luminescence measurements were conducted in a MicroLumat Plus LB96V (Berthold Technologies, Bad Wildbad, Germany) recorded after addition of the luciferase substrates. Instrument readings of both luciferase recordings were normalized by generating a ratio between firefly luciferase and Renilla luciferase.
- NEENA molecules comprising sequences with SEQ ID NO1, NO2, NO3, NO4, NO5, NO6, NO7, NO8 and NO9 conferred a greater than 2-fold increase in gene expression based on luciferase reporter gene activity compared to the NEENA-less promoter-only reporter gene construct ( Fig. 1 ) and hence are functional NEENA molecules. Since a number of the tested NEENA candidate molecules have marginal or even negative effects on the enhancement of gene expression, not all putative NEENA molecules are mediating a common stimulatory effect, but rather that the selected NEENA sequences convey significant enhancement of gene expression (SEQ ID NO. 1 to 9).
- Example 3 Test of NEENA molecules for enhancement of gene expression in oilseed rape plants
- NEENA molecules can be used across species to enhance gene expression in all tissues tested compared to a NEENA-less promoter-only approach.
- NEENA molecules mediating the strongest enhancement in gene expression in the pre-screening cp. Example 2, SEQ ID NO1, NO2, NO3, NO4 and NO5 were selected for determining the enhancement on gene expression levels in transgenic oilseed rape plants.
- reporter gene expression cassettes without and with gene expression control molecules (SEQ IDs NO1 - NO5) were combined with a gene expression cassette carrying a selectable marker gene for detecting transgenic plant lines within a pENTR/C vector.
- LR-reaction site specific recombination
- the pENTR/A, pENTR/B and the pENTR/C carrying the selectable marker cassette were combined with the pSUN destination vector according to the manufacturers (Invitrogen, Carlsbad, CA, USA) Multisite Gateway manual.
- the binary vectors were transformed into Agrobacterium tumefaciens C58C1:pGV2260 ( Deblaere et al., 1985, Nucl. Acids. Res. 13: 4777-4788 ).
- a 1:50 dilution of an overnight culture of Agrobacteria harboring the respective binary construct was grown in Murashige-Skoog Medium ( Murashige and Skoog, 1962, Physiol. Plant 15, 473 ) supplemented with 3 % saccharose (3MS-Medium).
- Growing shoots were transferred to MS-Medium containing 2 % saccharose, 250 mg/l Claforan and 0,8 % Bacto-agar. After 3 weeks, the growth hormone 2-Indolbutyl acid was added to the medium to promote root formation. Shoots were transferred to soil following root development, grown for two weeks in a growth chamber and grown to maturity in greenhouse conditions.
- Tissue samples were collected from the generated transgenic plants from leaves, flowers and siliques, stored in a freezer at -80°C subjected to a Luciferase reporter gene assay (amended protocol after Ow et al., 1986). After grinding the frozen tissue samples were resuspended in 800 microl of buffer I (0,1 M Phosphate buffer pH7,8, 1 mM DTT (Sigma Aldrich, St. Louis, MO, USA), 0,05 % Tween 20 (Sigma Aldrich, St. Louis, MO, USA)) followed by centrifugation at 10 000 g for 10 min. 75 microl of the aqueous supernatant were transferred to 96-well plates.
- buffer I 0.,1 M Phosphate buffer pH7,8, 1 mM DTT (Sigma Aldrich, St. Louis, MO, USA), 0,05 % Tween 20 (Sigma Aldrich, St. Louis, MO, USA)
- the protein concentration was determined in the aqueous supernatant in parallel to the luciferase activity (adapted from Bradford, 1976, Anal. Biochem. 72, 248 ). 5 microl of the aqueous cell extract in buffer I were mixed with 250 microl of Bradford reagent (Sigma Aldrich, St. Louis, MO, USA), incubated for 10 min at room temperature. Absorption was determined at 595 nm in a plate reader (Thermo Electron Corporation, Multiskan Ascent 354). The total protein amounts in the samples were calculated with a previously generated standard concentration curve. Values resulting from a ratio of RLU/min and mg protein/ml sample were averaged for transgenic plants harboring identical constructs and fold change values were calculated to assess the impact of NEENA molecule presence over NEENA-less reporter gene constructs.
- NEENA molecules SEQ ID NO:1, 2, 3, 4 and 5
- leafs, flowers and siliques harboring seeds of plants having identical developmental stages and which were grown under equal growth conditions were collected.
- the samples were taken from individual transgenic oilseed rape plant lines harboring either a promoter-only reporter gene construct or Luciferase reporter gene constructs containing a NEENA (SEQ ID NO1, 2, 3, 4 and 5). 10 seeds were collected from each transgenic event, processed and analyzed for Luciferase activity as described above (Example 3.3).
- NEENA molecules can be used in a wide array of plant species and across species borders from different plant families to enhance gene expression in all tissues compared to a NEENA-less promoter-only approach.
- NEENA sequence molecules mediating the strongest enhancement in gene expression in the pre-screening were selected for determining the enhancement on gene expression levels in transgenic soybean plants.
- Plant expression vectors LJK138, LJK139, LJK141, LJK142, LJK143 and LJK144 were used for stable soybean transformation.
- Soybean seed germination, propagation, A. rhizogenes and axillary meristem explant preparation, and inoculations were done as previously described ( WO2005/121345; Olhoft et al., 2007 ) with the exception that the constructs LJK138, LJK139, LJK141, LJK142, LJK143 and LJK144 (cp. example 3.1) each contained a mutated AHAS gene driven by the parsley ubiquitin promoter PcUbi4-2, mediating tolerance to imidazolinone herbicides for selection.
- Tissue samples were collected from the generated transgenic plants from leaves, flowers and seeds. The tissue samples were processed and analyzed as described above (cp. example 3.3) In comparison to the constitutive p-AtNit1 promoter-only NEENA-less reporter gene construct, the five tested NEENA molecules all mediated strong enhancements in gene expression in leaves ( Fig. 3a ). Comparable enhancement of gene expression mediated by NEENAs (SEQ ID NO1 to NO5) was detected in soybean flowers and siliques ( Fig. 3, b and c ).
- This example describes the analysis of NEENA sequences with SEQ ID NO 1, 2, 3, 4 and 5 in monocotyledonous plants.
- a pUC-based expression vector harboring an expression cassette composed of the NEENA-less, constitutive monocotyledonous promoter p-Ubi from Z. Mosa is combined with a coding sequence of the beta-Glucuronidase (GUS) gene followed by the nopaline synthase (NOS) transcriptional terminator.
- GUS beta-Glucuronidase
- NOS nopaline synthase transcriptional terminator.
- Genomic DNA is extracted from A. thaliana green tissue using the Qiagen DNeasy Plant Mini Kit (Qiagen, Hilden, Germany). Genomic DNA fragments containing NEENA molecules are isolated by conventional polymerase chain reaction (PCR). Primers are designed on the basis of the A.
- Amplification during the PCR and purification of the amplification products is carried out as detailed above (example 1.2).
- the digested products are purified with the Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany).
- NEENA PCR fragments are cloned separately upstream of the beta-Glucuronidase coding sequence using AscI restriction sites.
- the reaction yields one binary vector with the p-Ubi promoter, the beta-Glucuronidase coding sequence c-GUS and the t-nos terminator and five vectors harboring SEQ ID NO1, NO2, NO3, NO4 and NO5, immediately upstream of the beta-Glucuronidase coding sequence (Table 9), for which the combination with SEQ ID NO1 is given exemplary (SEQ ID NO75). Except for varying SEQ ID NO2 to NO5, the nucleotide sequence is identical in all vectors (Table 9).
- Table 9 Plant expression vectors plant expression vector Composition of the expression cassette Promoter::SEQ ID NO::reporter gene::terminator SEQ ID NO RTP2940 p-Ubi::-::c-GUS::t-nos LJK361 p-Ubi::SEQ ID NO1::c-GUS::t-nos 75 LJK362 p-Ubi::SEQ ID NO2::c-GUS::t-nos LJK363 p-Ubi::SEQ ID NO3::c-GUS::t-nos LJK364 p-Ubi::SEQ ID NO4::c-GUS::t-nos LJK365 p-Ubi::SEQ ID NO5::c-GUS::t-nos
- These experiments are performed by bombardment of monocotyledonous plant tissues or culture cells (Example 6.2.1), by PEG-mediated (or similar methodology) introduction of DNA to plant protoplasts (Example 6.2.2), or by Agrobacterium -mediated transformation (Example 6.3.3).
- the target tissue for these experiments can be plant tissues (e.g. leaf tissue), cultured plant cells (e.g. maize Black Mexican Sweetcorn (BMS), or plant embryos for Agrobacterium protocols.
- the plasmid constructs are isolated using Qiagen plasmid kit (cat# 12143). DNA is precipitated onto 0.6 microM gold particles (Bio-Rad cat# 165 -2262) according to the protocol described by Sanford et al. (1993) (Optimizing the biolistic process for different biological applications. Methods in Enzymology, 217: 483-509 ) and accelerated onto target tissues (e.g. two week old maize leaves, BMS cultured cells, etc .) using a PDS-1000/He system device (Bio-Rad). All DNA precipitation and bombardment steps are performed under sterile conditions at room temperature.
- BMS Black Mexican Sweet corn suspension cultured cells are propagated in BMS cell culture liquid medium [Murashige and Skoog (MS) salts (4.3 g/L), 3% (w/v) sucrose, myo-inositol (100 mg/L), 3 mg/L 2,4-dichlorophenoxyacetic acid (2,4-D), casein hydrolysate (1 g/L), thiamine (10 mg/L) and L-proline (1.15 g/L), pH 5.8]. Every week 10 mL of a culture of stationary cells are transferred to 40 mL of fresh medium and cultured on a rotary shaker operated at 110 rpm at 27°C in a 250 mL flask.
- 60 mg of gold particles in a siliconized Eppendorf tube are resuspended in 100% ethanol followed by centrifugation for 30 seconds.
- the pellet is rinsed once in 100% ethanol and twice in sterile water with centrifugation after each wash.
- the pellet is finally resuspended in 1 mL sterile 50% glycerol.
- the gold suspension is then divided into 50 microL aliquots and stored at 4°C.
- the following reagents are added to one aliquot: 5 microL of 1 microg/microL total DNA, 50 microL 2.5 M CaCl 2 , 20 microL 0.1 M spermidine, free base.
- the DNA solution is vortexed for 1 minute and placed at -80°C for 3 min followed by centrifugation for 10 seconds.
- the supernatant is removed.
- the pellet is carefully resuspended in 1 mL 100% ethanol by flicking the tube followed by centrifugation for 10 seconds.
- the supernatant is removed and the pellet is carefully resuspended in 50 microL of 100% ethanol and placed at -80°C until used (30 min to 4 hr prior to bombardment). If gold aggregates are visible in the solution the tubes are sonicated for one second in a waterbath sonicator just prior to use.
- two -week-old maize leaves are cut into pieces approximately 1 cm in length and placed ad-axial side up on osmotic induction medium M-N6-702 [N6 salts (3.96 g/L), 3% (w/v) sucrose, 1.5 mg/L 2,4 -dichlorophenoxyacetic acid (2,4-D), casein hydrolysate (100 mg/L), and L-proline (2.9 g/L), MS vitamin stock solution (1 mL/L), 0.2 M mannitol, 0.2 M sorbitol, pH 5.8]. The pieces are incubated for 1-2 hours.
- BMS cultured cells In the case of BMS cultured cells, one-week-old suspension cells are pelleted at 1000 g in a Beckman/Coulter Avanti J25 centrifuge and the supernatant is discarded. Cells are placed onto round ash-free No 42 Whatman filters as a 1/16 inch thick layer using a spatula. The filter papers holding the plant materials are placed on osmotic induction media at 27°C in darkness for 1-2 hours prior to bombardment. Just before bombardment the filters are removed from the medium and placed onto on a stack of sterile filter paper to allow the calli surface to partially dry.
- Each plate is shot with 6 microL of gold -DNA solution twice, at 1,800 psi for the leaf materials and at 1,100 psi for the BMS cultured cells.
- a sterilized wire mesh screen is laid on top of the sample.
- the filters holding the samples are transferred onto M-N6-702 medium lacking mannitol and sorbitol and incubated for 2 days in darkness at 27°C prior to transient assays.
- the transient transformation via microprojectile bombardment of other monocotyledonous plants are carried out using, for example, a technique described in Wang et al., 1988 (Transient expression of foreign genes in rice, wheat and soybean cells following particle bombardment.
- GUS staining is done by incubating the plant materials in GUS solution [100 mM NaHPO4, 10 mM EDTA, 0.05% Triton X100, 0.025% X-Gluc solution (5-bromo-4-chloro -3-indolyl-beta-D-glucuronic acid dissolved in DMSO), 10% methanol, pH 7.0] at 37 °C for 16-24 hours. Plant tissues are vacuum-infiltrated 2 times for 15 minutes to aid even staining. Analyses of luciferase activities are performed as described above (example 2 and 3.3). In comparison to the constitutive p-Ubi promoter-only NEENA-less reporter gene construct, the NEENA molecules all mediate strong enhancement in gene expression in these assays.
- Isolation of protoplasts is conducted by following the protocol developed by Sheen (1990) (Metabolic Repression of Transcription in Higher Plants. The Plant Cell 2 (10), 1027-1038 ). Maize seedlings are kept in the dark at 25°C for 10 days and illuminated for 20 hours before protoplast preparation.
- the middle part of the leaves are cut to 0.5 mm strips (about 6 cm in length) and incubated in an enzyme solution containing 1% (w/v) cellulose RS, 0.1% (w/v) macerozyme R10 (both from Yakult Honsha, Nishinomiya, Japan), 0.6 M mannitol, 10 mM Mes (pH 5.7), 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM beta-mercaptoethanol, and 0.1% BSA (w/v) for 3 hr at 23°C followed by gentle shaking at 80 rpm for 10 min to release protoplasts.
- 1% (w/v) cellulose RS, 0.1% (w/v) macerozyme R10 both from Yakult Honsha, Nishinomiya, Japan
- 0.6 M mannitol 10 mM Mes (pH 5.7)
- 1 mM CaCl 2 1 mM MgCl 2
- Protoplasts are collected by centrifugation at 100 x g for 2 min, washed once in cold 0.6 M mannitol solution, centrifuged, and resuspended in cold 0.6 M mannitol (2 x 10 6 /mL).
- a total of 50 microg plasmid DNA in a total volume of 100 microL sterile water is added into 0.5 mL of a suspension of maize protoplasts (1 x 10 6 cells/mL) and mixed gently.
- 0.5 mL PEG solution (40 % PEG 4,000, 100 mM CaNO 3 , 0.5 mannitol) is added and pre-warmed at 70°C with gentle shaking followed by addition of 4.5 mL MM solution (0.6 M mannitol, 15 mM MgCl 2 , and 0.1 % MES). This mixture is incubated for 15 minutes at room temperature.
- the protoplasts are washed twice by pelleting at 600 rpm for 5 min and resuspending in 1.0 mL of MMB solution [0.6 M mannitol, 4 mM Mes (pH 5.7), and brome mosaic virus (BMV) salts (optional)] and incubated in the dark at 25°C for 48 hr. After the final wash step, the protoplasts are collected in 3 mL MMB medium, and incubated in the dark at 25°C for 48 hr.
- the transient transformation of protoplasts of other monocotyledonous plants are carried out using, for example, a technique described in Hodges et al., 1991 (Transformation and regeneration of rice protoplasts. Biotechnology in agriculture No. 6, Rice Biotechnology.
- GUS staining is done by incubating the plant materials in GUS solution [100 mM NaHPO4, 10 mM EDTA, 0.05% Triton X100, 0.025% X-Gluc solution (5-bromo-4-chloro -3-indolyl-beta-D-glucuronic acid dissolved in DMSO), 10% methanol, pH 7.0] at 37 °C for 16-24 hours. Analyses of luciferase activities are performed as described above (Example 2 and 3.3). In comparison to the constitutive p-Ubi promoter-only NEENA-less reporter gene construct, the NEENA molecules mediate strong enhancement in gene expression in these assays.
- the Agrobacterium -mediated plant transformation using standard transformation and regeneration techniques may also be carried out for the purposes of transforming crop plants ( Gelvin and Schilperoort, 1995, Plant Molecular Biology Manual, 2nd Edition, Dordrecht: Kluwer Academic Publ. ISBN 0-7923-2731-4 ; Glick and Thompson (1993) Methods in Plant Molecular Biology and Biotechnology, Boca Raton: CRC Press, ISBN 0-8493-5164-2 ).
- the transformation of maize or other monocotyledonous plants can be carried out using, for example, a technique described in US 5,591,616 .
- Expression levels of the expressed genes in the constructs described above are determined by GUS staining, quantification of luminescence or fluorescence, RT-PCR, protein abundance (detection by specific antibodies) using the protocols in the art.
- GUS staining is done by incubating the plant materials in GUS solution [100 mM NaHPO4, 10 mM EDTA, 0.05% Triton X100, 0.025% X-Gluc solution (5-bromo-4-chloro -3-indolyl-beta-D-glucuronic acid dissolved in DMSO), 10% methanol, pH 7.0] at 37 °C for 16-24 hours. Plant tissues are vacuum-infiltrated 2 times for 15 minutes to aid even staining. Analyses of luciferase activities are performed as described above (Examples 2 and 3.3).
- the NEENA molecules mediate strong enhancement in gene expression in plants.
- This example describes the analysis of NEENA sequences with SEQ ID NO 1 and 2 in corn plants.
- a pUC-based expression vector harboring an expression cassette composed of the NEENA-less, constitutive monocotyledonous promoter p-Ubi from Z grass was combined with a coding sequence of the firefly luciferase (LUC) gene (Promega, Madison, WI, USA) followed by the nopaline synthase (NOS) transcriptional terminator.
- LOC firefly luciferase
- NOS nopaline synthase
- Amplification during the PCR and purification of the amplification products was carried out as detailed above (example 1.2). Following a DNA restriction digest with MluI (10 U/microl) and AscI (10 U/microl) restriction endonucleases, the digested products were purified with the Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany).
- NEENA PCR fragments were cloned separately upstream of the firefly luciferase coding sequence using AscI restriction sites.
- the reaction yielded one binary vector with the p-Ubi promoter, the firefly luciferase coding sequence c-LUC and the t-nos terminator and two vectors harboring SEQ ID NO1 and NO2, immediately upstream of the firefly luciferase coding sequence (Table 11), for which the combination with SEQ ID NO1 is given exemplary (SEQ ID NO80). Except for varying SEQ ID NO2, the nucleotide sequence is identical in the vectors (Table 11).
- Table 11 Plant expression vectors plant expression vector Composition of the expression cassette Promoter::SEQ ID NO::reporter gene::terminator SEQ ID NO LJK309 p-Ubi::-::c-LUC::t-nos LJK327 p-Ubi::SEQ ID NO1::c-LUC::t-nos 80 LJK326 p-Ubi::SEQ ID NO2::c-LUC::t-nos
- Tissue samples were collected from the generated transgenic plants from leaves and kernels. The tissue samples were processed and analyzed as described above (cp. example 3.3)
- This example describes the analysis of NEENA sequences with SEQ ID NO 1 in rice plants.
- pENTR/B vectors LJK1 and LJK4 were combined with a destination vector harboring the constitutive PRO0239 upstream of the recombination site using site specific recombination (LR-reaction) according to the manufacturers (Invitrogen, Carlsbad, CA, USA) Gateway manual.
- the reactions yielded one binary vector with PRO0239 promoter, the firefly luciferase coding sequence c-LUC and the t-nos terminator as well as 1 vector harboring SEQ ID NO1 immediately upstream of the firefly luciferase coding sequence (Table 12),.
- Table 12 Plant expression vectors plant expression vector Composition of the expression cassette Promoter::SEQ ID NO::reporter gene::terminator SEQ ID NO p-PRO0239 CD30963 ::-::c-LUC::t-nos p-PRO0239 CD30964 ::SEQ ID NO1::c-LUC::t-nos -
- the Agrobacterium containing the respective expression vector was used to transform Oryza sativa plants. Mature dry seeds of the rice japonica cultivar Nipponbare were dehusked. Sterilization was carried out by incubating for one minute in 70% ethanol, followed by 30 minutes in 0.2% HgCl 2 , followed by a 6 times 15 minutes wash with sterile distilled water. The sterile seeds were then germinated on a medium containing 2,4-D (callus induction medium). After incubation in the dark for four weeks, embryogenic, scutellum-derived calli were excised and propagated on the same medium. After two weeks, the calli were multiplied or propagated by subculture on the same medium for another 2 weeks. Embryogenic callus pieces were subcultured on fresh medium 3 days before co-cultivation (to boost cell division activity).
- Agrobacterium strain LBA4404 containing the respective expression vector was used for co-cultivation.
- Agrobacterium was inoculated on AB medium with the appropriate antibiotics and cultured for 3 days at 28°C.
- the bacteria were then collected and suspended in liquid co-cultivation medium to a density (OD 600 ) of about 1.
- the suspension was then transferred to a Petri dish and the calli immersed in the suspension for 15 minutes.
- the callus tissues were then blotted dry on a filter paper and transferred to solidified, co-cultivation medium and incubated for 3 days in the dark at 25°C.
- Co-cultivated calli were grown on 2,4-D-containing medium for 4 weeks in the dark at 28°C in the presence of a selection agent.
- T0 rice transformants Approximately 35 independent T0 rice transformants were generated for one construct. The primary transformants were transferred from a tissue culture chamber to a greenhouse. After a quantitative PCR analysis to verify copy number of the T-DNA insert, only single copy transgenic plants that exhibit tolerance to the selection agent were kept for harvest of T1 seed. Seeds were then harvested three to five months after transplanting. The method yielded single locus transformants at a rate of over 50 % (Aldemita and Hodges1996, Chan et al. 1993, Hiei et al. 1994).
- Tissue samples were collected from the generated transgenic plants from leaves and kernels. The tissue samples were processed and analyzed as described above (cp. example 3.3)
- the tested NEENA molecule (SEQ ID NO 1) mediated strong enhancements in gene expression in leaves ( Fig. 5a ). Strong enhancement of gene expression mediated by the NEENA (SEQ ID NO1) was detected in rice seeds ( Fig. 5b ).
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19183559.4A EP3581657B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23823009P | 2009-08-31 | 2009-08-31 | |
EP09169019 | 2009-08-31 | ||
PCT/EP2010/061659 WO2011023537A1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
EP10751837.5A EP2473610B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
Related Parent Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10751837.5A Division-Into EP2473610B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
EP10751837.5A Division EP2473610B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
PCT/EP2010/061659 Previously-Filed-Application WO2011023537A1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19183559.4A Division EP3581657B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
EP19183559.4A Previously-Filed-Application EP3581657B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
EP19183559.4A Division-Into EP3581657B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3153585A2 EP3153585A2 (en) | 2017-04-12 |
EP3153585A3 EP3153585A3 (en) | 2017-07-05 |
EP3153585B1 true EP3153585B1 (en) | 2019-10-09 |
Family
ID=42938516
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10751837.5A Active EP2473610B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
EP16194415.2A Active EP3153585B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
EP19183559.4A Active EP3581657B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10751837.5A Active EP2473610B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19183559.4A Active EP3581657B1 (en) | 2009-08-31 | 2010-08-11 | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
Country Status (15)
Country | Link |
---|---|
US (4) | US9828607B2 (es) |
EP (3) | EP2473610B1 (es) |
JP (1) | JP5794986B2 (es) |
KR (1) | KR20120092104A (es) |
CN (3) | CN102482684B (es) |
AR (3) | AR078010A1 (es) |
AU (4) | AU2010288758B2 (es) |
CA (5) | CA3090172C (es) |
DE (1) | DE112010003500T5 (es) |
IL (1) | IL218094A0 (es) |
MX (1) | MX2012002047A (es) |
RU (1) | RU2012112347A (es) |
SG (1) | SG178389A1 (es) |
WO (1) | WO2011023537A1 (es) |
ZA (1) | ZA201202246B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3090172C (en) | 2009-08-31 | 2023-12-12 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
EP3418387B1 (en) | 2009-08-31 | 2020-11-25 | Basf Plant Science Company GmbH | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
CA3167819A1 (en) | 2009-08-31 | 2011-03-03 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
CN105838717A (zh) | 2011-03-18 | 2016-08-10 | 巴斯夫植物科学有限公司 | 用于调节在植物中的表达的启动子 |
WO2013005152A1 (en) * | 2011-07-05 | 2013-01-10 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
US20140237682A1 (en) * | 2011-07-19 | 2014-08-21 | Tedd D. Elich | Regulatory polynucleotides and uses thereof |
AU2012310193A1 (en) * | 2011-09-15 | 2014-03-06 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for reliable gene expression in plants |
EP2677035A1 (en) | 2012-06-22 | 2013-12-25 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
EP2816115A1 (en) | 2013-06-17 | 2014-12-24 | BASF Plant Science Company GmbH | Plants having one or more enhanced yield-related traits and a method for making the same |
MX2016000225A (es) | 2013-07-05 | 2016-06-15 | Basf Plant Science Co Gmbh | Elementos potenciadores de la expresion o actividad genica. |
EP2896698A1 (en) | 2014-01-17 | 2015-07-22 | BASF Plant Science Company GmbH | Plants having one or more enhanced yield-related traits and a method for making the same |
CN106148344B (zh) * | 2016-06-30 | 2019-05-03 | 中国农业大学 | 一种具有增强植物基因表达活性的5′utr序列及其应用 |
EP3500666A4 (en) | 2016-08-17 | 2020-04-08 | Monsanto Technology LLC | METHODS AND COMPOSITIONS FOR SMALL-SIZED PLANTS THROUGH THE MANIPULATION OF GIBBERRELL METABOLISM TO INCREASE HARVEST YIELD |
US20220220495A1 (en) * | 2019-05-10 | 2022-07-14 | Basf Se | Regulatory nucleic acid molecules for enhancing gene expression in plants |
US20230203515A1 (en) * | 2019-09-12 | 2023-06-29 | Basf Se | Regulatory Nucleic Acid Molecules for Enhancing Gene Expression in Plants |
WO2021069387A1 (en) * | 2019-10-07 | 2021-04-15 | Basf Se | Regulatory nucleic acid molecules for enhancing gene expression in plants |
EP4069852A1 (en) * | 2019-12-03 | 2022-10-12 | Basf Se | Regulatory nucleic acid molecules for enhancing gene expression in plants |
CN114317594B (zh) * | 2021-08-30 | 2023-06-06 | 中国科学院南京土壤研究所 | 拟南芥种子调控基因rpp1a的应用 |
CN113957073B (zh) * | 2021-10-19 | 2023-09-01 | 山东寿光巨能金玉米开发有限公司 | 一种tkt基因启动子突变体及其在生产L-赖氨酸中的应用 |
CN115568304A (zh) * | 2022-09-09 | 2023-01-06 | 西北农林科技大学 | 一种破除黑褐苔草种子休眠的方法 |
WO2024083579A1 (en) * | 2022-10-20 | 2024-04-25 | Basf Se | Regulatory nucleic acid molecules for enhancing gene expression in plants |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5232A (en) * | 1847-08-07 | Fike-gkate | ||
ZA88319B (en) * | 1987-02-06 | 1988-08-12 | Lubrizol Enterprises, Inc. | Ocs enhancer |
WO1993020216A1 (en) | 1991-02-22 | 1993-10-14 | University Technologies International, Inc. | Oil-body protein cis-elements as regulatory signals |
EP0604662B1 (en) | 1992-07-07 | 2008-06-18 | Japan Tobacco Inc. | Method of transforming monocotyledon |
EP0733059B1 (en) | 1993-12-09 | 2000-09-13 | Thomas Jefferson University | Compounds and methods for site-directed mutations in eukaryotic cells |
US5750866A (en) | 1994-09-08 | 1998-05-12 | American Cyanamid Company | AHAS promoter useful for expression of introduced genes in plants |
WO1999067389A2 (en) | 1995-05-15 | 1999-12-29 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada | Cryptic regulatory elements obtained from plants |
US5994123A (en) | 1996-08-09 | 1999-11-30 | Regents Of University Of Minnesota | Sugarcane bacilliform virus promoter |
US6555732B1 (en) | 1998-09-14 | 2003-04-29 | Pioneer Hi-Bred International, Inc. | Rac-like genes and methods of use |
US20110014706A2 (en) | 1998-12-14 | 2011-01-20 | Monsanto Technology Llc | Arabidopsis thaliana Genome Sequence and Uses Thereof |
EP1033405A3 (en) * | 1999-02-25 | 2001-08-01 | Ceres Incorporated | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
JP2004512806A (ja) | 1999-03-18 | 2004-04-30 | ユニバーシティ オブ シカゴ | 植物セントロメア |
US8877916B2 (en) | 2000-04-26 | 2014-11-04 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
WO2001098480A2 (en) * | 2000-06-23 | 2001-12-27 | Syngenta Participations Ag | Promoters for regulation of plant gene expression |
AU8681101A (en) | 2000-08-24 | 2002-03-04 | Scripps Research Inst | Stress-regulated genes of plants, transgenic plants containing same, and methodsof use |
US8022272B2 (en) | 2001-07-13 | 2011-09-20 | Sungene Gmbh & Co. Kgaa | Expression cassettes for transgenic expression of nucleic acids |
AU2002319285A1 (en) | 2001-07-13 | 2003-03-03 | Sungene Gmbh And Co. Kgaa | Expression cassettes for transgenically expressing selection markers |
EP1409697B1 (de) | 2001-07-13 | 2008-04-30 | Sungene GmbH & Co. KGaA | Expressionskassetten zur transgenen expression von nukleinsäuren |
DE10224889A1 (de) * | 2002-06-04 | 2003-12-18 | Metanomics Gmbh & Co Kgaa | Verfahren zur stabilen Expression von Nukleinsäuren in transgenen Pflanzen |
US7803983B2 (en) | 2004-06-30 | 2010-09-28 | Ceres, Inc. | Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
US7402667B2 (en) | 2003-10-14 | 2008-07-22 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
US20100170002A1 (en) | 2006-03-24 | 2010-07-01 | Ceres, Inc. | Promoter, promoter control elements, and combinations, and uses thereof |
US20070006335A1 (en) * | 2004-02-13 | 2007-01-04 | Zhihong Cook | Promoter, promoter control elements, and combinations, and uses thereof |
AU2005219533B2 (en) | 2004-03-01 | 2010-03-04 | Basf Plant Science Gmbh | Transgenic expression constructs for vegetative plant tissue specific expression of nucleic acids |
ES2463474T3 (es) * | 2004-05-13 | 2014-05-28 | Cropdesign N.V. | Procedimiento para aumentar la expresión de transgén |
EP1756282B1 (en) | 2004-06-07 | 2009-04-08 | BASF Plant Science GmbH | Improved transformation of soybean |
EP1614754A1 (en) | 2004-07-06 | 2006-01-11 | Biogemma | Method for enhancing gene expression in plants |
AU2005287547B2 (en) | 2004-09-23 | 2010-09-02 | Basf Plant Science Gmbh | Recombination cassettes and methods for sequence excision in plants |
EP2163632A1 (en) * | 2004-10-05 | 2010-03-17 | SunGene GmbH | Constitutive expression cassettes for regulation of plant expression |
ATE525473T1 (de) * | 2004-10-05 | 2011-10-15 | Sungene Gmbh | Konstitutive expressionskassette zur regulierung der expression in pflanzen. |
WO2006076099A2 (en) | 2004-12-08 | 2006-07-20 | Ceres, Inc. | Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass in plants |
CA2596600A1 (en) | 2005-02-09 | 2006-08-17 | Basf Plant Science Gmbh | Expression cassettes for regulation of expression in monocotyledonous plants |
CA2598436A1 (en) | 2005-02-22 | 2006-08-31 | Ceres, Inc. | Modulating plant alkaloids |
WO2006089950A2 (en) | 2005-02-26 | 2006-08-31 | Basf Plant Science Gmbh | Expression cassettes for seed-preferential expression in plants |
US7994399B2 (en) | 2005-06-23 | 2011-08-09 | Basf Plant Science Gmbh | Methods for the production of stably transformed, fertile Zea mays plants |
EP2980220A1 (en) | 2005-09-20 | 2016-02-03 | BASF Plant Science GmbH | Improved methods controlling gene expression |
US20070204367A1 (en) | 2006-02-17 | 2007-08-30 | Stanislaw Flasinski | Chimeric regulatory sequences comprising introns for plant gene expression |
EP1996712A2 (en) | 2006-03-17 | 2008-12-03 | BASF Plant Science GmbH | D-amino acid selection for soybean |
DE102006034313A1 (de) | 2006-07-21 | 2008-01-24 | Basf Plant Science Gmbh | Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure |
US8222388B2 (en) * | 2006-11-22 | 2012-07-17 | Ceres, Inc. | Broadly expressing regulatory regions |
WO2008104559A1 (de) | 2007-02-27 | 2008-09-04 | Norddeutsche Pflanzenzucht | Verfahren zur herstellung von mehrfach ungesättigten fettsäuren in transgenen organismen |
AP2009004993A0 (en) | 2007-04-04 | 2009-10-31 | Basf Plant Science Gmbh | Ahas mutants |
DE112008001989A5 (de) | 2007-07-31 | 2010-06-10 | Basf Plant Science Gmbh | Desaturasen und Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenen Organismen |
EP2594647A3 (en) * | 2007-09-21 | 2013-07-24 | BASF Plant Science GmbH | Plants with increased yield |
EP3418387B1 (en) | 2009-08-31 | 2020-11-25 | Basf Plant Science Company GmbH | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
CA3167819A1 (en) | 2009-08-31 | 2011-03-03 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
CA3090172C (en) | 2009-08-31 | 2023-12-12 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
AU2012310193A1 (en) | 2011-09-15 | 2014-03-06 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for reliable gene expression in plants |
-
2010
- 2010-08-11 CA CA3090172A patent/CA3090172C/en active Active
- 2010-08-11 KR KR1020127008218A patent/KR20120092104A/ko not_active Application Discontinuation
- 2010-08-11 CN CN201080038708.6A patent/CN102482684B/zh active Active
- 2010-08-11 DE DE112010003500T patent/DE112010003500T5/de not_active Withdrawn
- 2010-08-11 CA CA3031259A patent/CA3031259C/en active Active
- 2010-08-11 CN CN201510543571.4A patent/CN105132425B/zh active Active
- 2010-08-11 EP EP10751837.5A patent/EP2473610B1/en active Active
- 2010-08-11 JP JP2012525978A patent/JP5794986B2/ja not_active Expired - Fee Related
- 2010-08-11 CA CA3235747A patent/CA3235747A1/en active Pending
- 2010-08-11 EP EP16194415.2A patent/EP3153585B1/en active Active
- 2010-08-11 EP EP19183559.4A patent/EP3581657B1/en active Active
- 2010-08-11 US US13/393,028 patent/US9828607B2/en active Active
- 2010-08-11 SG SG2012009940A patent/SG178389A1/en unknown
- 2010-08-11 RU RU2012112347/10A patent/RU2012112347A/ru not_active Application Discontinuation
- 2010-08-11 WO PCT/EP2010/061659 patent/WO2011023537A1/en active Application Filing
- 2010-08-11 MX MX2012002047A patent/MX2012002047A/es not_active Application Discontinuation
- 2010-08-11 CA CA2771252A patent/CA2771252C/en active Active
- 2010-08-11 CA CA3175433A patent/CA3175433C/en active Active
- 2010-08-11 AU AU2010288758A patent/AU2010288758B2/en active Active
- 2010-08-11 CN CN201810999543.7A patent/CN109468339B/zh active Active
- 2010-08-31 AR ARP100103188A patent/AR078010A1/es unknown
-
2012
- 2012-02-14 IL IL218094A patent/IL218094A0/en unknown
- 2012-03-28 ZA ZA2012/02246A patent/ZA201202246B/en unknown
-
2016
- 2016-04-12 AU AU2016202274A patent/AU2016202274B2/en active Active
-
2017
- 2017-10-20 AU AU2017248552A patent/AU2017248552B2/en active Active
- 2017-10-31 US US15/798,492 patent/US10689657B2/en active Active
-
2019
- 2019-07-03 AR ARP190101882A patent/AR116107A2/es unknown
- 2019-07-03 AR ARP190101883A patent/AR115692A2/es unknown
- 2019-10-07 AU AU2019240730A patent/AU2019240730B2/en active Active
-
2020
- 2020-06-22 US US16/907,693 patent/US11708578B2/en active Active
-
2023
- 2023-07-24 US US18/357,691 patent/US20240035040A1/en active Pending
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11708578B2 (en) | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants | |
US10041081B2 (en) | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants | |
US20140230087A1 (en) | Regulatory Nucleic Acid Molecules for Enhancing Constitutive Gene Expression in Plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2473610 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01H 5/00 20060101ALN20170526BHEP Ipc: C12N 15/82 20060101AFI20170526BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180105 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20181026 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01H 5/00 20180101ALN20181214BHEP Ipc: C12N 15/82 20060101AFI20181214BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/82 20060101AFI20190218BHEP Ipc: A01H 5/00 20180101ALN20190218BHEP |
|
INTG | Intention to grant announced |
Effective date: 20190320 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2473610 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602010061496 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1188846 Country of ref document: AT Kind code of ref document: T Effective date: 20191115 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20191009 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1188846 Country of ref document: AT Kind code of ref document: T Effective date: 20191009 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200110 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200109 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200109 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200210 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200224 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602010061496 Country of ref document: DE |
|
PG2D | Information on lapse in contracting state deleted |
Ref country code: IS |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200209 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 |
|
26N | No opposition filed |
Effective date: 20200710 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20200811 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200811 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200811 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200811 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191009 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230517 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20230902 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230828 Year of fee payment: 14 Ref country code: BE Payment date: 20230825 Year of fee payment: 14 |